血液学の最新論文（2020年6月リリース分）New reports on Hematology
Leukemia
- Blood MYC-induced Human Acute Myeloid Leukemia Requires a Continuing IL3/GM-CSF Co-Stimulus Blood. 2020 Jun 29:blood.2020006374. doi: 10.1182/blood.2020006374. Bulaeva E, Pellacani D, Nakamichi N, Hammond CA, Beer P, Lorzadeh A, Moksa M, Carles A, Bilenky M, Lefort S, Shu JY, Wilhelm B, Weng A, Hirst M, Eaves CJ
- Blood How I Treat Relapsed Acute Lymphoblastic Leukemia in the Pediatric Population Blood. 2020 Jun 26:blood.2019004043. doi: 10.1182/blood.2019004043. Hunger SP, Raetz E
- Blood Synergistic Targeting of FLT3 Mutations in AML via Combined Menin-MLL and FLT3 Inhibition Blood. 2020 Jun 26:blood.2020005037. doi: 10.1182/blood.2020005037. Dzama MM, Steiner M, Rausch J, Sasca D, Schönfeld J, Kunz K, Taubert MC, McGeehan GM, Chen CW, Mupo A, Hähnel PS, Theobald M, Kindler T, Koche RP, Vassiliou GS, Armstrong SA, Kühn MWM
- Blood Hematopoietic Stem Cells Acquire Survival Advantage by Loss of RUNX1 Methylation Identified in Familial Leukemia Blood. 2020 Jun 23:blood.2019004292. doi: 10.1182/blood.2019004292. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CQ, Tokunaga K, Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T
- Blood Association of Aberrant ASNS Imprinting With Asparaginase Sensitivity and Chromosomal Abnormality in Childhood BCP-ALL Blood. 2020 Jun 23:blood.2019004090. doi: 10.1182/blood.2019004090. Watanabe A, Miyake K, Nordlund J, Syvänen AC, van der Weyden L, Honda H, Yamasaki N, Nagamachi A, Inaba T, Ikawa T, Urayama KY, Kiyokawa N, Ohara A, Kimura S, Kubota Y, Takita J, Goto H, Sakaguchi K, Minegishi M, Iwamoto S, Shinohara T, Kagami K, Abe M, Akahane K, Goi K, Sugita K, Inukai T
- Blood CHRONIC LYMPHOCYTIC LEUKEMIA MANAGEMENT IN ITALY DURING THE COVID-19 PANDEMIC. A CAMPUS CLL REPORT Blood. 2020 Jun 19:blood.2020006854. doi: 10.1182/blood.2020006854. Cuneo A, Scarfo L, Reda G, Varettoni M, Quaglia FM, Marchetti M, De Paoli L, Re F, Pietrasanta D, Rigolin GM, Orsucci L, Ibatici A, Gattei V, Mauro FR, Trentin L, Laurenti L, Marasca R, Foà R
- Blood Quantitative Proteomics Reveals Specific Metabolic Features of Acute Myeloid Leukemia Stem Cells Blood. 2020 Jun 18:blood.2019003654. doi: 10.1182/blood.2019003654. Raffel S, Klimmeck D, Falcone M, Demir A, Pouya A, Zeisberger P, Lutz C, Tinelli M, Bischel O, Bullinger L, Thiede C, Flörcken A, Westermann J, Ehninger G, Ho AD, Müller-Tidow C, Gu Z, Herrmann C, Krijgsveld J, Trumpp A, Hansson J
- Blood Sensitive, Rapid Diagnostic Test For Transient Abnormal Myelopoiesis and Myeloid Leukemia of Down Syndrome Blood. 2020 Jun 18:blood.2020005610. doi: 10.1182/blood.2020005610. Cruz Hernandez D, Metzner M, de Groot AP, Usukhbayar B, Elliott N, Roberts I, Vyas P
- Blood CML: New Tools to Answer Old Questions 135(26):2327-2328 Giotopoulos G, Huntly BJP
- Blood Genetics in the Era of Targeted CLL Therapy 135(26):2333-2334 Stankovic T, Kwok M
- Blood An Integrative Model of Pathway Convergence in Genetically Heterogeneous Blast Crisis Chronic Myeloid Leukemia 135(26):2337-2353 Ko TK, Javed A, Lee KL, Pathiraja TN, Liu X, Malik S, Soh SX, Heng XT, Takahashi N, Tan JHJ, Bhatia R, Khng AJ, Chng WJ, Sia YY, Fruman DA, Ng KP, Chan ZE, Xie KJ, Hoi Q, Chan CX, Teo ASM, Velazquez Camacho O, Meah WY, Khor CC, Ong CTJ, Soon WJW, Tan P, Ng PC, Chuah C, Hillmer AM, Ong ST
- Blood Prognostic and Predictive Impact of Genetic Markers in Patients With CLL Treated With Obinutuzumab and Venetoclax 135(26):2402-2412 Tausch E, Schneider C, Robrecht S, Zhang C, Dolnik A, Bloehdorn J, Bahlo J, Al-Sawaf O, Ritgen M, Fink AM, Eichhorst B, Kreuzer KA, Tandon M, Humphrey K, Jiang Y, Schary W, Bullinger L, Mertens D, Lurà MP, Kneba M, Döhner H, Fischer K, Hallek M, Stilgenbauer S
- Blood Ldb1 Is Required for Lmo2 Oncogene-Induced Thymocyte Self-Renewal and T-cell Acute Lymphoblastic Leukemia 135(25):2252-2265 Li L, Mitra A, Cui K, Zhao B, Choi S, Lee JY, Stamos DB, El-Khoury D, Warzecha C, Pfeifer K, Hardwick J, Zhao K, Venters B, Davé UP, Love PE
- Blood BTK Inhibitor Therapy Is Effective in Patients With CLL Resistant to Venetoclax 135(25):2266-2270 Lin VS, Lew TE, Handunnetti SM, Blombery P, Nguyen T, Westerman DA, Kuss BJ, Tam CS, Roberts AW, Seymour JF, Anderson MA
- Blood Increased Tumor Burden in Chronic Myeloid Leukemia Patients After 36 Months of Imatinib Discontinuation Blood. 2020 Jun 9:blood.2019004371. doi: 10.1182/blood.2019004371. Diral E, Mori S, Antolini L, Abruzzese E, le Coutre P, Martino B, Pungolino E, Elena C, Bergamaschi M, Assouline S, Di Bona E, Gozzini A, Andrade Campos MM, Stagno F, Iurlo A, Pirola A, Fontana D, Petiti J, Bonanomi ML, Crivori P, Piazza R, Fava C, Gambacorti-Passerini CB
- Blood Cost-Effectiveness of First-Line Ibrutinib Versus Third-Line in Patients With Untreated Chronic Lymphocytic Leukemia Blood. 2020 Jun 9:blood.2020004922. doi: 10.1182/blood.2020004922. Patel K, Isufi I, Kothari S, Davidoff AJ, Gross CP, Huntington SF
- Blood How I Treat Relapsed or Refractory AML Blood. 2020 Jun 9:blood.2019001982. doi: 10.1182/blood.2019001982. DeWolf SE, Tallman MS
- Blood Does Time From Diagnosis to Treatment Affect the Prognosis of Patients With Newly Diagnosed Acute Myeloid Leukemia? Blood. 2020 Jun 4:blood.2019004583. doi: 10.1182/blood.2019004583. Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Noppeney R, Schäfer-Eckart K, Krause SW, Haenel M, Herbst R, Kunzmann V, Einsele H, Jost E, Brümmendorf TH, Scholl S, Hochhaus A, Neubauer A, Sohlbach K, Fransecky L, Kaufmann M, Niemann D, Schaich M, Frickhofen N, Kiani A, Heits F, Krümpelmann U, Kaiser U, Kullmer J, Wass M, Stölzel F, von Bonin M, Middeke JM, Thiede C, Schetelig J, Berdel WE, Ehninger G, Baldus C, Müller-Tidow C, Platzbecker U, Serve H, Bornhauser M
- Blood Impact of TKI Maintenance Post-Allogeneic Transplant in Philadelphia Positive Acute Lymphoblastic Leukemia Blood. 2020 Jun 3:blood.2019004685. doi: 10.1182/blood.2019004685. Saini NY, Marin D, Ledesma C, Delgado R, Rondon G, Popat U, Bashir Q, Hosing C, Nieto Y, Alousi A, Qazilbash MH, Ciurea SO, Shpall EJ, Khouri IF, Kantarjian HM, Jabbour E, Ravandi F, Champlin R, Kebriaei P
- Blood Preclinical Efficacy of Humanized, non-FcγR Binding Anti-CD3 Antibodies in T-cell Acute Lymphoblastic Leukemia Blood. 2020 Jun 1:blood.2019003801. doi: 10.1182/blood.2019003801. Tran Quang C, Zaniboni B, Humeau R, Lengline E, Dourthe ME, Ganesan R, Singh S, Scheer JM, Asnafi V, Ghysdael J
- Blood The Long Road: Improving Outcome in Elderly “Unfit” AML? 135(24):2114-2115 Löwenberg B, Huls G
- Blood ON TRacK Towards Novel Targets in Leukemia 135(24):2117-2119 Eisfeld AK
- Blood Venetoclax Plus LDAC for Newly Diagnosed AML Ineligible for Intensive Chemotherapy: A Phase 3 Randomized Placebo-Controlled Trial 135(24):2137-2145 Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, Jiang Q, Mendes W, Hayslip J, Panayiotidis P
- Blood Novel BCL2 Mutations in Venetoclax-Resistant, Ibrutinib-Resistant CLL Patients With BTK/PLCG2 Mutations 135(24):2192-2195 Lucas F, Larkin K, Gregory CT, Orwick S, Doong TJ, Lozanski A, Lozanski G, Misra S, Ngankeu A, Ozer HG, Sampath D, Thangavadivel S, Yilmaz SA, Rogers KA, Byrd JC, Woyach JA, Blachly JS
- Blood Predicting the Future: Adult T-cell Leukemia 135(23):2013-2014 Ratner L
- Blood Decoding Ribosomes to Keep Growing (In AML) 135(23):2015-2016 An J, Ko M
- Blood Evolution of Retrovirus-Infected Premalignant T-cell Clones Prior to Adult T-cell Leukemia/Lymphoma Diagnosis 135(23):2023-2032 Rowan AG, Dillon R, Witkover A, Melamed A, Demontis MA, Gillet NA, Mun LJ, Bangham CRM, Cook LB, Fields PA, Taylor GP
- Blood Site-specific Methylation of 18S Ribosomal RNA by SNORD42A Is Required for Acute Myeloid Leukemia Cell Proliferation 135(23):2059-2070 Pauli C, Liu Y, Rohde C, Cui C, Fijalkowska D, Gerloff D, Walter C, Krijgsveld J, Dugas M, Edemir B, Pabst C, Müller LP, Zhou F, Müller-Tidow C
- Br J Haematol Medical Comorbidities in Patients With Chronic Lymphocytic Leukaemia Treated With Idelalisib: Analysis of Two Large Randomised Clinical Trials Br J Haematol. 2020 Jun 29. doi: 10.1111/bjh.16879. Gordon MJ, Huang J, Chan RJ, Bhargava P, Danilov AV
- Br J Haematol Successful Treatment of Chronic Myelomonocytic Leukaemia With Hydroxycarbamide in a Patient Presenting With Acute Hypoxic Respiratory Failure Due to COVID-19 Pneumonia Br J Haematol. 2020 Jun 27. doi: 10.1111/bjh.16978. Chopra J, Hiew HJ, Cumpstey A, Cagampang F, Jenner MW, Dushianthan A
- Br J Haematol The Loss or Absence of Minimal Residual Disease of <0·1% at Any Time After Two Cycles of Consolidation Chemotherapy in CBFB-MYH11-positive Acute Myeloid Leukaemia Indicates Poor Prognosis Br J Haematol. 2020 Jun 25. doi: 10.1111/bjh.16745. Duan W, Liu X, Jia J, Wang J, Gong L, Jiang Q, Zhao T, Wang Y, Zhang X, Xu L, Zhao X, Qin Y, Shi H, Chang Y, Huang X, Jiang H
- Br J Haematol Successful Remission Induction Therapy With Gilteritinib in a Patient With De Novo FLT3-mutated Acute Myeloid Leukaemia and Severe COVID-19 Br J Haematol. 2020 Jun 25. doi: 10.1111/bjh.16962. Wilson AJ, Troy-Barnes E, Subhan M, Clark F, Gupta R, Fielding AK, Kottaridis P, Mansour MR, O'Nions J, Payne E, Chavda N, Baker R, Thomson K, Khwaja A
- Br J Haematol Blastic Transformation of BCR-ABL1 Positive Chronic Myeloid Leukaemia Through Acquisition of CBFB-MYH11 and Mutant KIT Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16904. Shoumariyeh K, Hussung S, Niemöller C, Bleul S, Veratti P, Follo M, Riba J, Philipp U, Palmer JM, Pfeifer D, Pantic M, Meggendorfer M, Hackanson B, Finke J, Haferlach T, Duyster J, Miething C, Becker H, von Bubnoff N
- Br J Haematol ROR1 Is an Accurate and Reliable Marker of Minimal Residual Disease in Chronic Lymphocytic Leukaemia Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16910. De Propris MS, Intoppa S, Milani ML, Mariglia P, Nardacci MG, Peragine N, Foà R, Guarini A
- Br J Haematol In Chronic Lymphocytic Leukaemia, SLAMF1 Deregulation Is Associated With Genomic Complexity and Independently Predicts a Worse Outcome Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16865. Rigolin GM, Saccenti E, Melandri A, Cavallari M, Urso A, Rotondo F, Betulla A, Tognolo L, Bardi MA, Rossini M, Tammiso E, Bassi C, Cavazzini F, Negrini M, Antonio C
- Br J Haematol Acute Megakaryoblastic Leukaemia With t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an Adult Patient Following a Non-Mediastinal Germ Cell Tumour Br J Haematol. 2020 Jun 23. doi: 10.1111/bjh.16900. Saito Y, Makita S, Chinen S, Kito M, Fujino T, Ida H, Hosoba R, Tanaka T, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Miyagi-Maeshima A, Matsushita H, Izutsu K
- Br J Haematol Combination Treatment With CPX-351 and Midostaurin in Patients With Secondary Acute Myeloid Leukaemia That Are FLT3 Mutated: Three Cases and Review of Literature Br J Haematol. 2020 Jun 21. doi: 10.1111/bjh.16800. Andrews C, Maze D, Murphy T, Sibai H
- Br J Haematol Younger Age at Diagnosis of Acute Promyelocytic Leukaemia Is Associated With Better Long-Term Cognitive Functioning Br J Haematol. 2020 Jun 18. doi: 10.1111/bjh.16877. Breccia M, Vignetti M, Annibali O, Cottone F, Luppi M, Borlenghi E, Rodeghiero F, Efficace F
- Br J Haematol Unexpected Kinetics of anti-SARS-CoV-2 Total Antibodies in Two Patients With Chronic Lymphocytic Leukemia Br J Haematol. 2020 Jun 17:10.1111/bjh.16954. doi: 10.1111/bjh.16954. Favresse J, Eucher C, Elsen M, Graux C, Goebels P, Laffineur K, Nicolas JB, Dogné JM, Douxfils J
- Br J Haematol Concomitant Haemorrhagic Syndrome and Recurrent Extensive Arterial Thrombosis in a Patient With COVID-19 and Acute Promyelocytic Leukaemia 189(6):1054-1056 Baldacini M, Pop R, Sattler L, Mauvieux L, Bilger K, Gantzer J, Schneider F, Beaujeux R, Simand C, Herbrecht R
- Br J Haematol Correction of Bcl-x Splicing Improves Responses to Imatinib in Chronic Myeloid Leukaemia Cells and Mouse Models 189(6):1141-1150 Zhang J, Wang Y, Li SQ, Fang L, Wang XZ, Li J, Zhang HB, Huang B, Xu YM, Yang WM, Lin J, Min QH, Liao ZH, Wu Y, Liu J
- Br J Haematol T-lymphoblastic Lymphoma and Acute Myeloid Leukaemia Transformed From Myeloid Neoplasm With Eosinophilia: A Divergent Evolution of Myeloid Neoplasm With Monosomy 7 but No Detectable Tyrosine Kinase Gene Rearrangements Designated by the WHO Classification Br J Haematol. 2020 Jun 11. doi: 10.1111/bjh.16886. Yang LH, Zhao Y, Maule J, Rapisardo S, Wang E
- Br J Haematol Secondary Plasma Cell Leukaemia Treated With Single Agent Venetoclax Br J Haematol. 2020 Jun 11. doi: 10.1111/bjh.16858. Glavey SV, Flanagan L, Bleach R, Kelly C, Quinn J, Ní Chonghaile T, Murphy P
- Br J Haematol An Ex Vivo Investigation of Interactions Between Primary Acute Myeloid Leukaemia and Mesenchymal Stromal Cells Yields Novel Therapeutic Targets Br J Haematol. 2020 Jun 10. doi: 10.1111/bjh.16810. Chowdhury A, Loaiza S, Yebra-Fernandez E, Nadal-Melsio E, Apperley JF, Khorashad JS
- Br J Haematol Clinical Outcome and Prognostic Factors of Patients With Richter Syndrome: Real-World Study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC) Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16748. Abrisqueta P, Delgado J, Alcoceba M, Oliveira AC, Loscertales J, Hernández-Rivas JA, Ferrà C, Cordoba R, Yáñez L, Medina A, Motlló C, Iacoboni G, Villacampa G, González M, Bosch F
- Br J Haematol Clinical Outcomes in T-cell Large Granular Lymphocytic Leukaemia: Prognostic Factors and Treatment Response Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16808. Braunstein Z, Mishra A, Staub A, Freud AG, Porcu P, Brammer JE
- Br J Haematol A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukaemia Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16804. Fiedler W, Chromik J, Amberg S, Kebenko M, Thol F, Schlipfenbacher V, Christine Wilke A, Modemann F, Janning M, Serve H, Ganser A, Bokemeyer C, Theile S, Deppermann U, Kranich AL, Heuser M
- Br J Haematol High Prevalence and Incidence of Cardiovascular Disease in Chronic Lymphocytic Leukaemia: A Nationwide Population-Based Study Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16859. Larsson K, Mattsson M, Ebrahim F, Glimelius I, Höglund M
- Br J Haematol Low-density Lipoprotein Receptor (LDLR) Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukaemia Br J Haematol. 2020 Jun 8. doi: 10.1111/bjh.16853. Floeth M, Elges S, Gerss J, Schwöppe C, Kessler T, Herold T, Wardelmann E, Berdel WE, Lenz G, Mikesch JH, Hartmann W, Schliemann C, Angenendt L
- Br J Haematol Acute Myeloid Leukemia With NPM1 Mutation and Favorable European LeukemiaNet Category: Outcome After Preemptive Intervention Based on Measurable Residual Disease Br J Haematol. 2020 Jun 8. doi: 10.1111/bjh.16857. Bataller A, Oñate G, Diaz-Beyá M, Guijarro F, Garrido A, Vives S, Tormo M, Arnan M, Salamero O, Sampol A, Coll R, Vall-Llovera F, Oliver-Caldés A, López-Guerra M, Pratcorona M, Zamora L, Villamon E, Roué G, Blanco A, Nomdedeu JF, Colomer D, Brunet S, Sierra J, Esteve J; Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias (CETLAM)
- Br J Haematol Prognostic Scoring Systems and Comorbidities in Chronic Myelomonocytic Leukaemia: A Nationwide Population-Based Study Br J Haematol. 2020 Jun 5. doi: 10.1111/bjh.16790. Moreno Berggren D, Kjellander M, Backlund E, Engvall M, Garelius H, Lorenz F, Nilsson L, Rasmussen B, Lehmann S, Hellström-Lindberg E, Jädersten M, Ungerstedt J, Ejerblad E
- Br J Haematol Interleukin-6 Blockade Treatment for COVID-19 Associated Cytokine Release Syndrome in a Patient With Poorly Controlled Chronic Myeloid Leukaemia Br J Haematol. 2020 Jun 1. doi: 10.1111/bjh.16901. Ranger A, Haji R, Kaczmarski R, Danga A
- Br J Haematol High Frequency of STAT3 Gene Mutations in T-cell Receptor (TCR)γδ-type T-cell Large Granular Lymphocytic Leukaemia: Implications for Molecular Diagnostics Br J Haematol. 2020 Jun 1. doi: 10.1111/bjh.16820. Yamane T, Kawakami T, Sekiguchi N, Kobayashi J, Ueki T, Kobayashi H, Kawakami F, Nishina S, Sakai H, Oshimi K, Higuchi Y, Nakazawa H, Ishida F
- Br J Haematol Outcomes of Allogeneic Stem Cell Transplantation for Patients With t(6:9) AML- A Strong Case for Allogeneic Stem Cell Transplantation in First Complete Remission 189(5):806-808 Stahl M, Tallman MS
- Br J Haematol Immunoglobulin Heavy Variable Somatic Hyper Mutation Status in Chronic Lymphocytic Leukaemia: On the Threshold of a New Era? 189(5):809-810 Langerak AW, Davi F, Stamatopoulos K
- Br J Haematol Dissecting the Role of the CXCL12/CXCR4 Axis in Acute Myeloid Leukaemia 189(5):815-825 Ladikou EE, Chevassut T, Pepper CJ, Pepper AG
- Br J Haematol Redefining the Prognostic Likelihood of Chronic Lymphocytic Leukaemia Patients With Borderline Percentage of Immunoglobulin Variable Heavy Chain Region Mutations 189(5):853-859 Raponi S, Ilari C, Della Starza I, Cappelli LV, Cafforio L, Piciocchi A, Arena V, Mariglia P, Mauro FR, Gentile M, Cutrona G, Moia R, Favini C, Morabito F, Rossi D, Gaidano G, Guarini A, Del Giudice I, Foà R
- Br J Haematol Allogeneic Stem Cell Transplantation in AML With t(6;9)(p23;q34);DEK-NUP214 Shows a Favourable Outcome When Performed in First Complete Remission 189(5):920-925 Díaz-Beyá M, Labopin M, Maertens J, Alijurf M, Passweg J, Dietrich B, Schouten H, Socié G, Schaap N, Schwerdtfeger R, Volin L, Michallet M, Polge E, Sierra J, Mohty M, Esteve J, Nagler A; Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
- Haematologica Infrequent “Chronic Lymphocytic Leukemia-Specific” Immunoglobulin Stereotypes in Aged Individuals With or Without Low Count Monoclonal B Cell Lymphocytosis Haematologica. 2020 Jun 25:haematol.2020.247908. doi: 10.3324/haematol.2020.247908. Agathangelidis A, Galigalidou C, Scarfò L, Moysiadis T, Rovida A, Gounari M, Psomopoulos F, Ranghetti P, Galanis A, Davi F, Stamatopoulos K, Chatzidimitriou A, Ghia P
- Haematologica Chronic Lymphocytic Leukaemia and Prolymphocytic Leukaemia. Two Coins or Two Sides of the Same Coin? Haematologica. 2020 Jun 25:haematol.2020.253062. doi: 10.3324/haematol.2020.253062. Magnano L, Navarro A, López-Guerra M, Clot G, Beà S, Bastidas G, Costa D, Rivero A, Garrote M, Giné E, Rozman M, Aymerich M, Colomer D, López-Guillermo A, Campo E, Villamor N, Matutes E
- Haematologica Targeting GLUT1 in Acute Myeloid Leukemia to Overcome Cytarabine Resistance Haematologica. 2020 Jun 18:haematol.2020.246843. doi: 10.3324/haematol.2020.246843. Åbacka H, Hansen JS, Huang P, Venskutonytė R, Hyrenius-Wittsten A, Poli G, Tuccinardi T, Granchi C, Minutolo F, Hagström-Andersson AK, Lindkvist-Petersson K
- Haematologica Comparison of Total Body Irradiation Versus Non- Total Body Irradiation Containing Regimens for De Novo Acute Myeloid Leukemia in Children Haematologica. 2020 Jun 18:haematol.2020.249458. doi: 10.3324/haematol.2020.249458. Dandoy CE, Davies SM, Ahn KW, He Y, Kolb AE, Levine J, Bo-Subait S, Abdel-Azim H, Bhatt N, Chewing J, Gadalla S, Gloude N, Hayashi R, Lalefar NR, Law J, MacMillan M, O'Brien T, Prestidge T, Sharma A, Shaw P, Winestone L, Eapen M
- Haematologica Germline Pathogenic Variants in Transcription Factors Predisposing to Pediatric Acute Myeloid Leukemia: Results From the French ELAM02 Trial Haematologica. 2020 Jun 18:haematol.2020.248872. doi: 10.3324/haematol.2020.248872. Fenwarth L, Duployez N, Marceau-Renaut A, Abou Chahla W, Ducassou S, Gandemer V, Pasquet M, Leblanc T, Schneider P, Domenech C, Saultier P, Leverger G, Lapillonne H, Preudhomme C, Petit A
- Haematologica Efficacy of Minimal Residual Disease Driven Immune-Intervention After Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Chronic Lymphocytic Leukemia: Results of a Prospective Multicentric Trial Haematologica. 2020 Jun 11:haematol.2019.239566. doi: 10.3324/haematol.2019.239566. Tournilhac O, Le Garff-Tavernier M, Nguyen Quoc S, Forcade E, Chevallier P, Legrand-Izadifar F, Damaj GL, Michonneau D, Tomowiak C, Borel C, Orvain C, Turlure P, Redjou R, Guillerm G, Vincent L, Simand C, Lemal R, Quiney C, Combes P, Pereira B, Calvet L, Cabrespine A, Bay JO, Leblond V, Dhédin N; French Innovative Leukemia Organization (FILO); Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- Haematologica Frequency and Prognostic Impact of ZEB2 H1038 and 1072 Mutations in Childhood B-other Acute Lymphoblastic Leukemia Haematologica. 2020 Jun 4:haematol.2020.249094. doi: 10.3324/haematol.2020.249094. Zaliova M, Potuckova E, Lukes J Jr, Winkowska L, Starkova J, Janotova I, Sramkova L, Stary J, Zuna J, Stanulla M, Zimmermann M, Bornhauser B, Bourquin JP, Eckert C, Cario G, Trka J
- Haematologica Epigenetic and Functional Changes Imposed by NUP98-HOXA9 in a Genetically Engineered Model of Chronic Myeloid Leukemia Progression Haematologica. 2020 Jun 4:haematol.2020.249243. doi: 10.3324/haematol.2020.249243. Sloma I, Beer P, Desterke C, Bulaeva E, Bilenky M, Carles A, Moksa M, Raghuram K, Brimacombe C, Lambie K, Turhan AG, Wagner-Ballon O, Gaulard P, Humphries K, Hirst M, Eaves CJ
- Haematologica Outcomes of Relapsed or Refractory Acute Myeloid Leukemia After Frontline Hypomethylating Agent and Venetoclax Regimens Haematologica. 2020 Jun 4:haematol.2020.252569. doi: 10.3324/haematol.2020.252569. Maiti A, Rausch CR, Cortes JE, Pemmaraju N, Daver NG, Ravandi F, Garcia-Manero G, Borthakur G, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Kadia TM, Takahashi K, Yilmaz M, Jain N, Kornblau S, Montalban Bravo G, Sasaki K, Andreeff M, Bose P, Ferrajoli A, Issa GC, Jabbour EJ, Masarova L, Thompson PA, Wang S, Konoplev S, Pierce SA, Ning J, Qiao W, Welch JS, Kantarjian HM, DiNardo CD, Konopleva MY
- Haematologica To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia 105(6):1470-1472 Sallman DA
- Haematologica The Increasing Complexity of the Management of Core-Binding Factor Acute Myeloid Leukemia 105(6):1475-1477 Litzow MR
- Haematologica Clinical Practice Recommendation on Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients With FLT3-internal Tandem Duplication: A Position Statement From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 105(6):1507-1516 Bazarbachi A, Bug G, Baron F, Brissot E, Ciceri F, Dalle IA, Döhner H, Esteve J, Floisand Y, Giebel S, Gilleece M, Gorin NC, Jabbour E, Aljurf M, Kantarjian H, Kharfan-Dabaja M, Labopin M, Lanza F, Malard F, Peric Z, Prebet T, Ravandi F, Ruggeri A, Sanz J, Schmid C, Shouval R, Spyridonidis A, Versluis J, Vey N, Savani BN, Nagler A, Mohty M
- Haematologica Synergistic Effects of PRIMA-1 Met (APR-246) and 5-azacitidine in TP53-mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia 105(6):1539-1551 Maslah N, Salomao N, Drevon L, Verger E, Partouche N, Ly P, Aubin P, Naoui N, Schlageter MH, Bally C, Miekoutima E, Rahmé R, Lehmann-Che J, Ades L, Fenaux P, Cassinat B, Giraudier S
- Haematologica The Prevalence of Extramedullary Acute Myeloid Leukemia Detected by 18 FDG-PET/CT: Final Results From the Prospective PETAML Trial 105(6):1552-1558 Stölzel F, Lüer T, Löck S, Parmentier S, Kuithan F, Kramer M, Alakel NS, Sockel K, Taube F, Middeke JM, Schetelig J, Röllig C, Paulus T, Kotzerke J, Ehninger G, Bornhäuser M, Schaich M, Zoephel K
- Haematologica Obesity Is a Risk Factor for Acute Promyelocytic Leukemia: Evidence From Population and Cross-Sectional Studies and Correlation With FLT3 Mutations and Polyunsaturated Fatty Acid Metabolism 105(6):1559-1566 Mazzarella L, Botteri E, Matthews A, Gatti E, Di Salvatore D, Bagnardi V, Breccia M, Montesinos P, Bernal T, Gil C, Ley TJ, Sanz M, Bhaskaran K, Coco FL, Pelicci PG
- Haematologica Low Level CpG Island Promoter Methylation Predicts a Poor Outcome in Adult T-cell Acute Lymphoblastic Leukemia 105(6):1575-1581 Touzart A, Boissel N, Belhocine M, Smith C, Graux C, Latiri M, Lhermitte L, Mathieu EL, Huguet F, Lamant L, Ferrier P, Ifrah N, Macintyre E, Dombret H, Asnafi V, Spicuglia S
- Haematologica A Laboratory-Based Scoring System Predicts Early Treatment in Rai 0 Chronic Lymphocytic Leukemia 105(6):1613-1620 Cohen JA, Rossi FM, Zucchetto A, Bomben R, Terzi-di-Bergamo L, Rabe KG, Degan M, Steffan A, Polesel J, Santinelli E, Innocenti I, Cutrona G, D'Arena G, Pozzato G, Zaja F, Chiarenza A, Rossi D, Di Raimondo F, Laurenti L, Gentile M, Morabito F, Neri A, Ferrarini M, Fegan CD, Pepper CJ, Del Poeta G, Parikh SA, Kay NE, Gattei V
- Haematologica IGHV Mutational Status and Outcome for Patients With Chronic Lymphocytic Leukemia Upon Treatment: A Danish Nationwide Population-Based Study 105(6):1621-1629 Rotbain EC, Frederiksen H, Hjalgrim H, Rostgaard K, Egholm GJ, Zahedi B, Poulsen CB, Enggard L, da Cunha-Bang C, Niemann CU
- Haematologica Allogeneic Stem Cell Transplantation in Second Complete Remission for Core Binding Factor Acute Myeloid Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 105(6):1723-1730 Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A
- Haematologica Yttrium-90-labeled anti-CD45 Antibody Followed by a Reduced-Intensity Hematopoietic Cell Transplantation for Patients With Relapsed/Refractory Leukemia or Myelodysplasia 105(6):1731-1737 Vo P, Gooley TA, Rajendran JG, Fisher DR, Orozco JJ, Green DJ, Gopal AK, Haaf R, Nartea M, Storb R, Appelbaum FR, Press OW, Pagel JM, Sandmaier BM
- Haematologica Inflammation Regulates Long Non-Coding RNA-PTTG1-1:1 in Myeloid Leukemia 105(6):e280-e284 Chateauvieux S, Gaigneaux A, Gérard D, Orsini M, Morceau F, Orlikova-Boyer B, Farge T, Récher C, Sarry JE, Dicato M, Diederich M
- Haematologica The microRNA miR-196b Acts as a Tumor Suppressor in Cdx2-driven Acute Myeloid Leukemia 105(6):e285-e289 Rawat VPS, Götze M, Rasalkar A, Vegi NM, Ihme S, Thoene S, Pastore A, Bararia D, Döhner H, Döhner K, Feuring-Buske M, Quintanilla-Fend L, Buske C
- Haematologica RNAmut: Robust Identification of Somatic Mutations in Acute Myeloid Leukemia Using RNA-sequencing 105(6):e290-e293 Gu M, Zwiebel M, Ong SH, Boughton N, Nomdedeu J, Basheer F, Nannya Y, Quiros PM, Ogawa S, Cazzola M, Rad R, Butler AP, Vijayabaskar MS, Vassiliou GS
- Haematologica Unique Clinico-Biological, Genetic and Prognostic Features of Adult Early T-cell Precursor Acute Lymphoblastic Leukemia 105(6):e294-e297 Genescà E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, González-Gil C, Zamora L, Ramírez JL, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Juncà J, Ciudad J, Orfao A, Ribera JM
- Haematologica High Frequency of Chronic Lymphocytic Leukemia-Like Low-Count Monoclonal B-cell Lymphocytosis in Japanese Descendants Living in Brazil 105(6):e298-e301 de Faria-Moss M, Yamamoto M, Arrais-Rodrigues C, Criado I, Gomes CP, de Lourdes Chauffaille M, Gonçalves MV, Kimura E, Koulieris E, Borges F, Dighiero G, Pesquero JB, Almeida J, Orfao A
- J Clin Oncol Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children’s Oncology Group Study AALL1131 J Clin Oncol. 2020 Jun 4:JCO1902892. doi: 10.1200/JCO.19.02892. Salzer WL, Burke MJ, Devidas M, Dai Y, Hardy KK, Kairalla JA, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, Wood B, Heerema NA, Carroll AJ, Winick N, Carroll WL, Raetz EA, Loh ML, Hunger SP
- J Clin Oncol Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group 38(17):1897-1905 Gupta S, Wang C, Raetz EA, Schore R, Salzer WL, Larsen EC, Maloney KW, Mattano LA Jr, Carroll WL, Winick NJ, Hunger SP, Loh ML, Devidas M
- Lancet Haematol Special Considerations in the Management of Adult Patients With Acute Leukaemias and Myeloid Neoplasms in the COVID-19 Era: Recommendations From a Panel of International Experts Lancet Haematol. 2020 Jun 18:S2352-3026(20)30205-2. doi: 10.1016/S2352-3026(20)30205-2. Zeidan AM, Boddu PC, Patnaik MM, Bewersdorf JP, Stahl M, Rampal RK, Shallis R, Steensma DP, Savona MR, Sekeres MA, Roboz GJ, DeAngelo DJ, Schuh AC, Padron E, Zeidner JF, Walter RB, Onida F, Fathi A, DeZern A, Hobbs G, Stein EM, Vyas P, Wei AH, Bowen DT, Montesinos P, Griffiths EA, Verma AK, Keyzner A, Bar-Natan M, Navada SC, Kremyanskaya M, Goldberg AD, Al-Kali A, Heaney ML, Nazha A, Salman H, Luger S, Pratz KW, Konig H, Komrokji R, Deininger M, Cirici BX, Bhatt VR, Silverman LR, Erba HP, Fenaux P, Platzbecker U, Santini V, Wang ES, Tallman MS, Stone RM, Mascarenhas J
- Leukemia COVID-19 Among Fit Patients With CLL Treated With Venetoclax-Based Combinations Leukemia. 2020 Jun 29. doi: 10.1038/s41375-020-0941-7. Fürstenau M, Langerbeins P, De Silva N, Fink AM, Robrecht S, von Tresckow J, Simon F, Hohloch K, Droogendijk J, van der Klift M, van der Spek E, Illmer T, Schöttker B, Fischer K, Wendtner CM, Tausch E, Stilgenbauer S, Niemann CU, Gregor M, Kater AP, Hallek M, Eichhorst B
- Leukemia The EUTOS Long-Term Survival (ELTS) Score Is Superior to the Sokal Score for Predicting Survival in Chronic Myeloid Leukemia Leukemia. 2020 Jun 29. doi: 10.1038/s41375-020-0931-9. Pfirrmann M, Clark RE, Prejzner W, Lauseker M, Baccarani M, Saussele S, Guilhot F, Heibl S, Hehlmann R, Faber E, Turkina A, Ossenkoppele G, Höglund M, Zaritskey A, Griskevicius L, Olsson-Strömberg U, Everaus H, Koskenvesa P, Labar B, Sacha T, Zackova D, Cervantes F, Colita A, Zupan I, Bogdanovic A, Castagnetti F, Guilhot J, Hasford J, Hochhaus A, Hoffmann VS
- Leukemia Requirement for LIM Kinases in Acute Myeloid Leukemia Leukemia. 2020 Jun 26. doi: 10.1038/s41375-020-0943-5. Jensen P, Carlet M, Schlenk RF, Weber A, Kress J, Brunner I, Słabicki M, Grill G, Weisemann S, Cheng YY, Jeremias I, Scholl C, Fröhling S
- Leukemia A Novel TLX1-driven T-ALL Zebrafish Model: Comparative Genomic Analysis With Other Leukemia Models Leukemia. 2020 Jun 26. doi: 10.1038/s41375-020-0938-2. Loontiens S, Vanhauwaert S, Depestel L, Dewyn G, Van Loocke W, Moore FE, Garcia EG, Batchelor L, Borga C, Squiban B, Malone-Perez M, Volders PJ, Olexiouk V, Van Vlierberghe P, Langenau DM, Frazer JK, Durinck K, Speleman F
- Leukemia Clonal Dominance Is an Adverse Prognostic Factor in Acute Myeloid Leukemia Treated With Intensive Chemotherapy Leukemia. 2020 Jun 24. doi: 10.1038/s41375-020-0932-8. Cerrano M, Duchmann M, Kim R, Vasseur L, Hirsch P, Thomas X, Quentin S, Pasanisi J, Passet M, Rabian F, Rahmé R, Lengliné E, Raffoux E, Dhédin N, Sébert M, Maarek O, Raimbault A, Celli-Lebras K, Adès L, Fenaux P, Boissel N, Delhommeau F, Soulier J, Dombret H, Clappier E, Sujobert P, Itzykson R
- Leukemia Effective Drug Treatment Identified by in Vivo Screening in a Transplantable Patient-Derived Xenograft Model of Chronic Myelomonocytic Leukemia Leukemia. 2020 Jun 24. doi: 10.1038/s41375-020-0929-3. Kloos A, Mintzas K, Winckler L, Gabdoulline R, Alwie Y, Jyotsana N, Kattre N, Schottmann R, Scherr M, Gupta C, Adams FF, Schwarzer A, Heckl D, Schambach A, Imren S, Humphries RK, Ganser A, Thol F, Heuser M
- Leukemia Male Predominance in AML Is Associated With Specific Preleukemic Mutations Leukemia. 2020 Jun 23. doi: 10.1038/s41375-020-0935-5. De-Morgan A, Meggendorfer M, Haferlach C, Shlush L
- Leukemia Bosutinib for Pretreated Patients With Chronic Phase Chronic Myeloid Leukemia: Primary Results of the Phase 4 BYOND Study Leukemia. 2020 Jun 22. doi: 10.1038/s41375-020-0915-9. Hochhaus A, Gambacorti-Passerini C, Abboud C, Gjertsen BT, Brümmendorf TH, Smith BD, Ernst T, Giraldo-Castellano P, Olsson-Strömberg U, Saussele S, Bardy-Bouxin N, Viqueira A, Leip E, Russell-Smith TA, Leone J, Rosti G, Watts J, Giles FJ; BYOND Study Investigators
- Leukemia Prognostic Models for Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Meta-Analysis Leukemia. 2020 Jun 21. doi: 10.1038/s41375-020-0924-8. Molica S, Giannarelli D
- Leukemia Impact of Covid-19 on the Treatment of Acute Myeloid Leukemia Leukemia. 2020 Jun 19:1–3. doi: 10.1038/s41375-020-0925-7. Ferrara F, Zappasodi P, Roncoroni E, Borlenghi E, Rossi G
- Leukemia Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia in the Era of Next Generation Sequencing Leukemia. 2020 Jun 19. doi: 10.1038/s41375-020-0923-9. Davi F, Langerak AW, de Septenville AL, Kolijn PM, Hengeveld PJ, Chatzidimitriou A, Bonfiglio S, Sutton LA, Rosenquist R, Ghia P, Stamatopoulos K; ERIC, the European Research Initiative on CLL, and the EuroClonality-NGS Working Group
- Leukemia A Proof of Concept Phase I/II Pilot Trial of LSD1 Inhibition by Tranylcypromine Combined With ATRA in refractory/relapsed AML Patients Not Eligible for Intensive Therapy Leukemia. 2020 Jun 19:1–11. doi: 10.1038/s41375-020-0892-z. Wass M, Göllner S, Besenbeck B, Schlenk RF, Mundmann P, Göthert JR, Noppeney R, Schliemann C, Mikesch JH, Lenz G, Dugas M, Wermke M, Röllig C, Bornhäuser M, Serve H, Platzbecker U, Foerster KI, Burhenne J, Haefeli WE, Müller LP, Binder M, Pabst C, Müller-Tidow C; Study Alliance Leukemia (SAL)
- Leukemia The Clinical Impact of PTPN11 Mutations in Adults With Acute Myeloid Leukemia Leukemia. 2020 Jun 19. doi: 10.1038/s41375-020-0920-z. Alfayez M, Issa GC, Patel KP, Wang F, Wang X, Short NJ, Cortes JE, Kadia T, Ravandi F, Pierce S, Assi R, Garcia-Manero G, DiNardo CD, Daver N, Pemmaraju N, Kantarjian H, Borthakur G
- Leukemia Chronic Myeloid Leukemia Management at the Time of the COVID-19 Pandemic in Italy. A Campus CML Survey Leukemia. 2020 Jun 18:1–2. doi: 10.1038/s41375-020-0904-z. Breccia M, Abruzzese E, Bocchia M, Bonifacio M, Castagnetti F, Fava C, Galimberti S, Gozzini A, Gugliotta G, Iurlo A, Latagliata R, Luciano L, Pregno P, Rege-Cambrin G, Rosti G, Stagno F, Tiribelli M, Foà R, Saglio G; Campus CML working group
- Leukemia Regional BCG Vaccination Policy in Former East- And West Germany May Impact on Both Severity of SARS-CoV-2 and Incidence of Childhood Leukemia Leukemia. 2020 Jun 18:1–3. doi: 10.1038/s41375-020-0871-4. Hauer J, Fischer U, Auer F, Borkhardt A
- Leukemia Targeted Deep Sequencing Reveals Clonal and Subclonal Mutational Signatures in Adult T-cell leukemia/lymphoma and Defines an Unfavorable Indolent Subtype Leukemia. 2020 Jun 17. doi: 10.1038/s41375-020-0900-3. Marçais A, Lhermitte L, Artesi M, Laurent C, Durkin K, Hahaut V, Rosewick N, Suarez F, Sibon D, Cheminant M, Avettand-Fenoel V, Bruneau J, Georges M, Pique C, Van den Broeke A, Asnafi V, Hermine O
- Leukemia Response to the Conjugate Pneumococcal Vaccine (PCV13) in Patients With Chronic Lymphocytic Leukemia (CLL) Leukemia. 2020 Jun 17. doi: 10.1038/s41375-020-0884-z. Mauro FR, Giannarelli D, Galluzzo CM, Vitale C, Visentin A, Riemma C, Rosati S, Porrazzo M, Pepe S, Coscia M, Trentin L, Gentile M, Raponi S, Micozzi A, Gentile G, Baroncelli S
- Leukemia Phase II Trial of CPX-351 in Patients With Acute Myeloid Leukemia at High Risk for Induction Mortality Leukemia. 2020 Jun 16. doi: 10.1038/s41375-020-0916-8. Issa GC, Kantarjian HM, Xiao L, Ning J, Alvarado Y, Borthakur G, Daver N, DiNardo CD, Jabbour E, Bose P, Jain N, Kadia TM, Naqvi K, Pemmaraju N, Takahashi K, Verstovsek S, Andreeff M, Kornblau SM, Estrov Z, Ferrajoli A, Garcia-Manero G, Ohanian M, Wierda WG, Ravandi F, Cortes JE
- Leukemia Prognostic Value of Minimal Residual Disease Measured by Flow-Cytometry in Two Cohorts of Infants With Acute Lymphoblastic Leukemia Treated According to Either MLL-Baby or Interfant Protocols Leukemia. 2020 Jun 12. doi: 10.1038/s41375-020-0912-z. Popov A, Buldini B, De Lorenzo P, Disarò S, Verzhbitskaya T, Movchan L, Giarin E, Shorikov E, Di Meglio A, Tsaur G, Parasole R, Miakova N, Boichenko E, Kondratchik K, Aleinikova O, Karachunskiy A, Roumiantsev A, Locatelli F, Biondi A, Pieters R, Valsecchi MG, Fechina L, Basso G
- Leukemia Donor-derived Acute Promyelocytic Leukemia Presenting as Myeloid Sarcoma in a Transplanted Kidney Leukemia. 2020 Jun 10. doi: 10.1038/s41375-020-0903-0. Wong RL, Ketcham M, Irwin T, Akilesh S, Zhang TY, Reyes JD, Edlefsen K, Jalikis F, Becker PS
- Leukemia Second Cancers in Adults With Acute Promyelocytic Leukemia Treated With or Without Arsenic Trioxide: A SEER-medicare Analysis Leukemia. 2020 Jun 9. doi: 10.1038/s41375-020-0905-y. Norsworthy KJ, Avagyan A, Bird ST, Li Y, Akhtar S, Liao J, Wernecke M, Deisseroth AB, Chuk M, MaCurdy TE, Swain R, Kelman JA, Farrell AT, de Claro RA, Pazdur R, Blumenthal G, Graham DJ
- Leukemia Primary Therapy and Relative Survival Among Elderly Patients With Chronic Myeloid Leukemia: A Population-Based Study in the Netherlands, 1989-2017 Leukemia. 2020 Jun 8. doi: 10.1038/s41375-020-0902-1. Ector GICG, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG
- Leukemia Notch Blockade Overcomes Endothelial Cell-Mediated Resistance of FLT3/ITD-positive AML Progenitors to AC220 Treatment Leukemia. 2020 Jun 8. doi: 10.1038/s41375-020-0893-y. Le Q, Hadland B, Meshinchi S, Bernstein I
- Leukemia A 9-gene Score for Risk Stratification in B-cell Acute Lymphoblastic Leukemia Leukemia. 2020 Jun 2. doi: 10.1038/s41375-020-0888-8. Yan F, Wong NC, Powell DR, Curtis DJ
- Leukemia Preclinical Efficacy of Gemcitabine in MLL-rearranged Infant Acute Lymphoblastic Leukemia Leukemia. 2020 Jun 2. doi: 10.1038/s41375-020-0895-9. Wander P, Cheung LC, Pinhanҫos SS, Jones L, Kerstjens M, Arentsen-Peters STCJM, Singh S, Chua GA, Castro PG, Schneider P, Dolman MEM, Koopmans B, Molenaar JJ, Pieters R, Zwaan CM, Kotecha RS, Stam RW
- Leukemia Detection of Chronic Lymphocytic Leukemia Subpopulations in Peripheral Blood by Phage Ligands of Tumor Immunoglobulin B Cell Receptors Leukemia. 2020 Jun 1. doi: 10.1038/s41375-020-0885-y. Mimmi S, Maisano D, Nisticò N, Vecchio E, Chiurazzi F, Ferrara K, Iannalfo M, D'Ambrosio A, Fiume G, Iaccino E, Quinto I
- Leukemia Expert Opinion-Management of Chronic Myeloid Leukemia After Resistance to Second-Generation Tyrosine Kinase Inhibitors 34(6):1495-1502 Hochhaus A, Breccia M, Saglio G, García-Gutiérrez V, Réa D, Janssen J, Apperley J
- Leukemia Effective Targeting of NAMPT in Patient-Derived Xenograft Models of High-Risk Pediatric Acute Lymphoblastic Leukemia 34(6):1524-1539 Somers K, Evans K, Cheung L, Karsa M, Pritchard T, Kosciolek A, Bongers A, El-Ayoubi A, Forgham H, Middlemiss S, Mayoh C, Jones L, Gupta M, Kees UR, Chernova O, Korotchkina L, Gudkov AV, Erickson SW, Teicher B, Smith MA, Norris MD, Haber M, Lock RB, Henderson MJ
- Leukemia Bone Marrow Niche-Derived Extracellular Matrix-Degrading Enzymes Influence the Progression of B-cell Acute Lymphoblastic Leukemia 34(6):1540-1552 Verma D, Zanetti C, Godavarthy PS, Kumar R, Minciacchi VR, Pfeiffer J, Metzler M, Lefort S, Maguer-Satta V, Nicolini FE, Burroni B, Fontenay M, Krause DS
- Leukemia The Clinical Mutatome of Core Binding Factor Leukemia 34(6):1553-1562 Opatz S, Bamopoulos SA, Metzeler KH, Herold T, Ksienzyk B, Bräundl K, Tschuri S, Vosberg S, Konstandin NP, Wang C, Hartmann L, Graf A, Krebs S, Blum H, Schneider S, Thiede C, Middeke JM, Stölzel F, Röllig C, Schetelig J, Ehninger G, Krämer A, Braess J, Görlich D, Sauerland MC, Berdel WE, Wörmann BJ, Hiddemann W, Spiekermann K, Bohlander SK, Greif PA
- Leukemia Immunomodulation With Pomalidomide at Early Lymphocyte Recovery After Induction Chemotherapy in Newly Diagnosed AML and High-Risk MDS 34(6):1563-1576 Zeidner JF, Knaus HA, Zeidan AM, Blackford AL, Montiel-Esparza R, Hackl H, Prince GT, Gondek LP, Ghiaur G, Showel MM, DeZern AE, Pratz KW, Douglas Smith B, Levis MJ, Gore S, Coombs CC, Foster MC, Streicher H, Karp JE, Luznik L, Gojo I
- Leukemia Impact of Pretransplant Measurable Residual Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML 34(6):1577-1587 Morsink LM, Othus M, Bezerra ED, Wood BL, Fang M, Sandmaier BM, Mielcarek M, Schoch G, Storb R, Deeg HJ, Appelbaum FR, Walter RB
- Leukemia The BET Inhibitor GS-5829 Targets Chronic Lymphocytic Leukemia Cells and Their Supportive Microenvironment 34(6):1588-1598 Kim E, Ten Hacken E, Sivina M, Clarke A, Thompson PA, Jain N, Ferrajoli A, Estrov Z, Keating MJ, Wierda WG, Bhalla KN, Burger JA
- Leukemia CRISPR/Cas9-generated Models Uncover Therapeutic Vulnerabilities of del(11q) CLL Cells to Dual BCR and PARP Inhibition 34(6):1599-1612 Quijada-Álamo M, Hernández-Sánchez M, Alonso-Pérez V, Rodríguez-Vicente AE, García-Tuñón I, Martín-Izquierdo M, Hernández-Sánchez JM, Herrero AB, Bastida JM, San Segundo L, Gruber M, García JL, Yin S, Ten Hacken E, Benito R, Ordóñez JL, Wu CJ, Hernández-Rivas JM
- Leukemia CD93 Is Expressed on Chronic Myeloid Leukemia Stem Cells and Identifies a Quiescent Population Which Persists After Tyrosine Kinase Inhibitor Therapy 34(6):1613-1625 Kinstrie R, Horne GA, Morrison H, Irvine D, Munje C, Castañeda EG, Moka HA, Dunn K, Cassels JE, Parry N, Clarke CJ, Scott MT, Clark RE, Holyoake TL, Wheadon H, Copland M
- Leukemia Two Unique HLA-A*0201 Restricted Peptides Derived From Cyclin E as Immunotherapeutic Targets in Leukemia 34(6):1626-1636 He H, Kondo Y, Ishiyama K, Alatrash G, Lu S, Cox K, Qiao N, Clise-Dwyer K, St John L, Sukhumalchandra P, Ma Q, Molldrem JJ
- Leukemia Quantitative Distribution of Patient-Derived Leukemia Clones in Murine Xenografts Revealed by Cellular Barcodes 34(6):1669-1674 Jacobs S, Ausema A, Zwart E, Weersing E, Kingma MJ, El Menshawi YAS, de Haan G, Bystrykh LV, Belderbos ME
- Leukemia Coordinated Inhibition of Nuclear Export and Bcr-Abl1 Selectively Targets Chronic Myeloid Leukemia Stem Cells 34(6):1679-1683 Than H, Pomicter AD, Yan D, Beaver LP, Eiring AM, Heaton WL, Senina A, Clair PM, Shacham S, Mason CC, Hare TO, Deininger MW
- Leukemia Insights on Mechanisms of Clonal Evolution in Chronic Neutrophilic Leukemia on Ruxolitinib Therapy 34(6):1684-1688 Stoner RC, Press RD, Maxson JE, Tyner JW, Dao KT
Lymphoma
- Blood Rosetting T Cells in Hodgkin Lymphoma Are Activated by Immunological Synapse Components HLA Class II and CD58 Blood. 2020 Jun 26:blood.2020005546. doi: 10.1182/blood.2020005546. Veldman J, Visser L, Huberts-Kregel M, Muller N, Hepkema B, Van den Berg A, Diepstra A
- Blood Genomic and Epigenomic Insights Into the Origin, Pathogenesis and Clinical Behavior of Mantle Cell Lymphoma Subtypes Blood. 2020 Jun 25:blood.2020005289. doi: 10.1182/blood.2020005289. Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggròs M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero I, Puente XS, Beà S, Campo E
- Blood Prediction and Prevention of Central Nervous System Relapse in Patients With Extranodal Natural killer/T-cell Lymphoma Blood. 2020 Jun 25:blood.2020005026. doi: 10.1182/blood.2020005026. Kim H, Jeong H, Yamaguchi M, Sohn I, Yoon SE, Byeon S, Hur JY, Koh Y, Yoon SS, Kim EJ, Oguchi M, Miyazaki K, Taguchi S, Yoon DH, Cho J, Ko YH, Kim SJ, Suzuki R, Kim WS
- Blood IL10RA Modulates Crizotinib Sensitivity in NPM1-ALK-positive Anaplastic Large Cell Lymphoma Blood. 2020 Jun 23:blood.2019003793. doi: 10.1182/blood.2019003793. Prokoph N, Probst NA, Lee LC, Monahan JM, Matthews JD, Liang HC, Bahnsen K, Montes-Mojarro IA, Karaca Atabay E, Sharma GG, Malik V, Larose H, Forde SD, Ducray SP, Lobello C, Wang Q, Luan SL, Pospisilova S, Gambacorti-Passerini CB, Burke A, Pervez S, Attarbaschi A, Janikova A, Pacquement H, Landman-Parker J, Lambilliotte A, Schleiermacher G, Klapper W, Jauch R, Woessmann W, Vassal G, Kenner L, Merkel O, Mologni L, Chiarle R, Brugieres L, Geoerger B, Barbieri I, Turner SD
- Blood Optimized Tandem CD19/CD20 CAR-engineered T Cells in refractory/relapsed B Cell Lymphoma Blood. 2020 Jun 18:blood.2020005278. doi: 10.1182/blood.2020005278. Tong C, Zhang Y, Liu Y, Ji X, Zhang WY, Guo Y, Han X, Ti D, Dai H, Wang C, Yang Q, Liu W, Wang Y, Wu Z, Han W
- Blood NLP Hodgkin Lymphoma: Can We Get Away With Less? 135(26):2329-2330 Moskowitz AJ
- Blood Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Multi-Institutional Study of Adult Patients by ILROG 135(26):2365-2374 Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT
- Blood Early Response Observed in Pediatric Patients With relapsed/refractory Burkitt Lymphoma Treated With Chimeric Antigen Receptor T Cells 135(26):2425-2427 Zhang W, Yang J, Zhou C, Hu B, Jin L, Deng B, Liu Y, Wang S, Chang AH, Du J, Gao Z, Zhang Y
- Blood Hemophagocytic Syndrome-Associated Intravascular Large B-cell Lymphoma 135(26):2432 Lindholm KE, Ewalt MD
- Blood ΔSUVmax for Interim PET in DLBCL: Old Is New 135(25):2202-2203 Meignan M, Gallamini A
- Blood Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results From the CALGB 50303 Clinical Trial 135(25):2224-2234 Schöder H, Polley MC, Knopp MV, Hall N, Kostakoglu L, Zhang J, Higley HR, Kelloff G, Liu H, Zelenetz AD, Cheson BD, Wagner-Johnston N, Kahl BS, Friedberg JW, Hsi ED, Leonard JP, Schwartz LH, Wilson WH, Bartlett NL
- Blood Transdifferentiation of Lymphoma Into Sarcoma Associated With Profound Reprogramming of Epigenome Blood. 2020 Jun 9:blood.2020005123. doi: 10.1182/blood.2020005123. Zhang Q, Orlando E, Wang H, Bogusz AM, Liu X, Lacey SF, Strauser HT, Nunez-Cruz S, Nejati R, Zhang P, Brooks S, Watt C, Melenhorst JJ, June CH, Schuster SJ, Wasik MA
- Blood Developing New Ceramide Analogs and Identifying Novel Sphingolipid Controlled Genes Against a Virus-Associated Lymphoma Blood. 2020 Jun 9:blood.2020005569. doi: 10.1182/blood.2020005569. Chen J, Goyal N, Dai L, Lin Z, Del Valle L, Zabaleta J, Liu J, Post S, Foroozesh M, Qin Z
- Blood Germline TET2 Loss-Of-Function Causes Childhood Immunodeficiency And Lymphoma Blood. 2020 Jun 9:blood.2020005844. doi: 10.1182/blood.2020005844. Stremenova Spegarova J, Lawless D, Mohamad SMB, Engelhardt KR, Doody GM, Shrimpton J, Rensing-Ehl A, Ehl S, Rieux-Laucat F, Cargo C, Griffin H, Mikulasova A, Acres M, Morgan NV, Poulter JA, Sheridan E, Chetcuti P, O'Riordan S, Anwar R, Carter CR, Przyborski S, Windebank K, Cant AJ, Lako M, Bacon C, Savic S, Hambleton S
- Blood Lenalidomide in Follicular Lymphoma 135(24):2133-2136 Flowers CR, Leonard JP, Fowler NH
- Blood Foreseeing What Is to Happen in DLBCL 135(23):2014-2015 Link BK
- Blood Evolution of Retrovirus-Infected Premalignant T-cell Clones Prior to Adult T-cell Leukemia/Lymphoma Diagnosis 135(23):2023-2032 Rowan AG, Dillon R, Witkover A, Melamed A, Demontis MA, Gillet NA, Mun LJ, Bangham CRM, Cook LB, Fields PA, Taylor GP
- Blood International Prognostic Indices in Diffuse Large B-cell Lymphoma: A Comparison of IPI, R-IPI, and NCCN-IPI 135(23):2041-2048 Ruppert AS, Dixon JG, Salles G, Wall A, Cunningham D, Poeschel V, Haioun C, Tilly H, Ghesquieres H, Ziepert M, Flament J, Flowers C, Shi Q, Schmitz N
- Blood Outcomes of Older Patients in ZUMA-1, a Pivotal Study of Axicabtagene Ciloleucel in Refractory Large B-cell Lymphoma 135(23):2106-2109 Neelapu SS, Jacobson CA, Oluwole OO, Munoz J, Deol A, Miklos DB, Bartlett NL, Braunschweig I, Jiang Y, Kim JJ, Zheng L, Rossi JM, Locke FL
- Br J Haematol Validation of the Simplified International Prognostic Score3 in a Hellenic Cohort of Patients With Advanced-Stage Hodgkin-lymphoma Br J Haematol. 2020 Jun 30. doi: 10.1111/bjh.16903. Asimakopoulos JV, Angelopoulou MK, Arapaki MP, Kanellopoulos A, Dimou M, Giakoumis X, Konstantinou E, Belia M, Chatzidimitriou C, Sachanas S, Iliakis T, Kyrtsonis MC, Siakantaris MP, Viniou NA, Variamis E, Kontopidou FN, Pangalis GA, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP
- Br J Haematol Update: The Investigation and Management of Follicular Lymphoma Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16872. McNamara C, Montoto S, Eyre TA, Ardeshna K, Burton C, Illidge T, Linton K, Rule S, Townsend W, Wong WL, McKay P
- Br J Haematol Two Independent Consecutive Lymphoma Cases Carry an Identical MYD88 Mutation but Differ in Their IGVH Rearrangement Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16917. Prieto-Torres L, Trascasa Á, Manso R, Machan S, Cieza-Diaz D, Olmedilla G, García-García M, Ara-Martín M, Requena L, Piris MÁ, Rodríguez-Pinilla SM
- Br J Haematol Addressing the Conundrum of Male Predominance in Mantle Cell Lymphoma Using Androgen Receptor Blockade Br J Haematol. 2020 Jun 22. doi: 10.1111/bjh.16902. Chow VA, Martin PS, Smith SD, Till BG, Graf SA, Edlefsen KL, Hannan LM, Mostaghel EA, Gopal AK
- Br J Haematol How I Treat Advanced Hodgkin Lymphoma – A Global View Br J Haematol. 2020 Jun 19. doi: 10.1111/bjh.16587. Hokland P, Shah M, David K, Evens A, Auer R, Ledieu R, Kreissl S, Bröckelmann PJ, Borchmann P, Korula A, Mathews V, Owattanapanich W, Trotman J
- Br J Haematol Is It Time to Rethink Checkpoint Blockade Therapy in non-Hodgkin Lymphoma? Br J Haematol. 2020 Jun 18. doi: 10.1111/bjh.16854. Phillips EH, Illidge TM
- Br J Haematol Maintenance Therapy With Ex Vivo Expanded Lymphokine-Activated Killer Cells and Rituximab in Patients With Follicular Lymphoma Is Safe and May Delay Disease Progression 189(6):1064-1073 López-Díaz de Cerio A, García-Muñoz R, Pena E, Panizo Á, Feliu J, Giraldo P, Rodríguez-Calvillo M, Martínez-Calle N, Grande C, Olave MT, Andrade-Campos M, Bandrés E, Núñez-Córdoba JM, Inogés S, Panizo C
- Br J Haematol Trends in the Prevalence, Incidence and Survival of non-Hodgkin Lymphoma Subtypes During the 21st Century – A Swedish Lymphoma Register Study 189(6):1083-1092 Ekberg S, E Smedby K, Glimelius I, Nilsson-Ehle H, Goldkuhl C, Lewerin C, Jerkeman M, Eloranta S
- Br J Haematol Improved Survival for Adolescents and Young Adults With Hodgkin Lymphoma and Continued High Survival for Children in the Netherlands: A Population-Based Study During 1990-2015 189(6):1093-1106 Reedijk AMJ, Zijtregtop EAM, Coebergh JWW, Meyer-Wentrup FAG, Hebeda KM, Zwaan CM, Janssens GOR, Pieters R, Plattel WJ, Dinmohamed AG, Zijlstra JM, Kremer LCM, Lugtenburg PJ, Beishuizen A, Karim-Kos HE
- Br J Haematol Cause-specific Mortality in Individuals With Lymphoplasmacytic lymphoma/Waldenström Macroglobulinaemia, 2000-2016 189(6):1107-1118 Dalal NH, Dores GM, Curtis RE, Linet MS, Morton LM
- Br J Haematol Pembrolizumab With R-CHOP in Previously Untreated Diffuse Large B-cell Lymphoma: Potential for Biomarker Driven Therapy 189(6):1119-1126 Smith SD, Till BG, Shadman MS, Lynch RC, Cowan AJ, Wu QV, Voutsinas J, Rasmussen HA, Blue K, Ujjani CS, Shustov A, Cassaday RD, Fromm JR, Gopal AK
- Br J Haematol Two Cases of Marked Red Cell Anisopoikilocytosis and Haemolysis With Alectinib, an Anaplastic Lymphoma Kinase Inhibitor Br J Haematol. 2020 Jun 14. doi: 10.1111/bjh.16813. Yuan Y, Mapp S, Xu W
- Br J Haematol T-lymphoblastic Lymphoma and Acute Myeloid Leukaemia Transformed From Myeloid Neoplasm With Eosinophilia: A Divergent Evolution of Myeloid Neoplasm With Monosomy 7 but No Detectable Tyrosine Kinase Gene Rearrangements Designated by the WHO Classification Br J Haematol. 2020 Jun 11. doi: 10.1111/bjh.16886. Yang LH, Zhao Y, Maule J, Rapisardo S, Wang E
- Br J Haematol The Flow Cytometric Characteristics of Breast Implant-Associated Anaplastic Large Cell Lymphoma Br J Haematol. 2020 Jun 11. doi: 10.1111/bjh.16763. Barr J, Campbell H, McGuire L, Cochrane T
- Br J Haematol Immunomodulatory Drugs May Overcome the Negative Prognostic Role of Active Th17 Axis in Follicular Lymphoma: Evidence From the SAKK35/10 Trial Br J Haematol. 2020 Jun 11. doi: 10.1111/bjh.16876. Menter T, Hayoz S, Zucca E, Kimby E, Dirnhofer S, Tzankov A
- Br J Haematol Validation of the RHL30 Digital Gene Expression Assay as a Prognostic Biomarker for Relapsed Hodgkin Lymphoma Br J Haematol. 2020 Jun 8. doi: 10.1111/bjh.16777. Calvente L, Tremblay-LeMay R, Xu W, Chan FC, Hong M, Zhang T, Yhim HY, Kuruvilla J, Crump M, Kukreti V, Prica A, Regier D, Marra MA, Karsan A, Steidl C, Scott DW, Sabatini P, Kridel R
- Br J Haematol Anaplastic Large Cell Lymphoma in Human Immunodeficiency Virus-Infected People and Solid Organ Transplant Recipients Br J Haematol. 2020 Jun 8. doi: 10.1111/bjh.16778. Mahale P, Weisenburger DD, Kahn AR, Gonsalves L, Pawlish K, Koch L, Tirado-Gomez M, Clarke CA, Alverson G, Shiels MS, Engels EA
- Br J Haematol Risk Stratification and Prognostic Biomarkers in Relapsed Hodgkin Lymphoma Br J Haematol. 2020 Jun 7. doi: 10.1111/bjh.16844. Bröckelmann PJ, von Tresckow B
- Br J Haematol Treatment of Relapsed/Refractory Paediatric Aggressive B-cell non-Hodgkin Lymphoma 189(5):826-843 Moleti ML, Testi AM, Foà R
- Br J Haematol Induction Therapy With the MATRix Regimen in Patients With Newly Diagnosed Primary Diffuse Large B-cell Lymphoma of the Central Nervous System – An International Study of Feasibility and Efficacy in Routine Clinical Practice 189(5):879-887 Schorb E, Fox CP, Kasenda B, Linton K, Martinez-Calle N, Calimeri T, Ninkovic S, Eyre TA, Cummin T, Smith J, Yallop D, De Marco B, Krampera M, Trefz S, Orsucci L, Fabbri A, Illerhaus G, Cwynarski K, Ferreri AJM
- Br J Haematol The Derived Neutrophil-To-Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Angioimmunoblastic T-cell Lymphoma 189(5):908-912 Hong H, Fang X, Huang H, Wang Z, Lin T, Yao H
- Haematologica Impact on Survival Through Consolidation Radiotherapy for Diffuse Large B-cell Lymphoma: A Comprehensive Meta-Analysis Haematologica. 2020 Jun 18:haematol.2020.249680. doi: 10.3324/haematol.2020.249680. Berger MD, Trelle S, Büchi AE, Jegerlehner S, Ionescu C, Lamy de la Chapelle T, Novak U
- Haematologica Peripheral T-cell Lymphoma Diagnosis: Building a Molecular Tool 105(6):1472-1474 Piris MA
- Haematologica Defining Signatures of Peripheral T-cell Lymphoma With a Targeted 20-marker Gene Expression Profiling Assay 105(6):1582-1592 Drieux F, Ruminy P, Abdel-Sater A, Lemonnier F, Viailly PJ, Fataccioli V, Marchand V, Bisig B, Letourneau A, Parrens M, Bossard C, Bruneau J, Dobay P, Veresezan L, Dupuy A, Pujals A, Robe C, Sako N, Copie-Bergman C, Delfau-Larue MH, Picquenot JM, Tilly H, Delarue R, Jardin F, de Leval L, Gaulard P
- Haematologica The Architecture of Neoplastic Follicles in Follicular Lymphoma; Analysis of the Relationship Between the Tumor and Follicular Helper T Cells 105(6):1593-1603 Townsend W, Pasikowska M, Yallop D, Phillips EH, Patten PEM, Salisbury JR, Marcus R, Pepper A, Devereux S
- Haematologica KMT2D Mutations and TP53 Disruptions Are Poor Prognostic Biomarkers in Mantle Cell Lymphoma Receiving High-Dose Therapy: A FIL Study 105(6):1604-1612 Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, da Silva MG, Santoro A, Molinari A, Ferreri A, Grønbæk K, Piccin A, Cortelazzo S, Bertoni F, Ladetto M, Gaidano G
- Haematologica Genetic Heterogeneity Highlighted by Differential FDG-PET Response in Diffuse Large B-cell Lymphoma 105(6):318-321 Araf S, Korfi K, Bewicke-Copley F, Wang J, Cogliatti S, Kumar E, Forrer F, Barrington SF, Graham TA, Scott DW, Rimsza LM, Davies A, Johnson P, Okosun J, Fitzgibbon J, Fehr M
- J Clin Oncol Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group J Clin Oncol. 2020 Jun 23:JCO1903160. doi: 10.1200/JCO.19.03160. Kreissl S, Müller H, Goergen H, Meissner J, Topp M, Sökler M, Markova J, Bernhard J, Greil R, von Tresckow B, Behringer K, Rüffer JU, Flechtner HH, Möstl M, Fuchs M, Engert A, Diehl V, Borchmann P
- J Clin Oncol Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children’s Oncology Group AALL0434 J Clin Oncol. 2020 Jun 17:JCO2000531. doi: 10.1200/JCO.20.00531. Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CM
- J Clin Oncol Should Flow Cytometry Be Considered a First Line of Study in the Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma? J Clin Oncol. 2020 Jun 17:JCO2000712. doi: 10.1200/JCO.20.00712. Romero M, Melo A, Bedoya N, de la Hoz J, Mejía-Arango M, Galvis K, Hernandez L, Cuellar G, Martin L, Quijano S, Saavedra C
- J Clin Oncol Molecular Risk Stratification in Aggressive B-Cell Lymphomas 38(18):2014-2017 Frosch ZAK, Landsburg DJ
- Lancet Haematol Molecular Imaging in Lymphoma Beyond 18 F-FDG-PET: Understanding the Biology and Its Implications for Diagnostics and Therapy 7(6):e479-e489 Kahle XU, Montes de Jesus FM, Glaudemans AWJM, Lub-de Hooge MN, Jorritsma-Smit A, Plattel WJ, van Meerten T, Diepstra A, van den Berg A, Kwee TC, Noordzij W, de Vries EGE, Nijland M
- Lancet Haematol Longitudinal Toxicity Over Time (ToxT) Analysis to Evaluate Tolerability: A Case Study of Lenalidomide in the CALGB 50401 (Alliance) Trial 7(6):e490-e497 Thanarajasingam G, Leonard JP, Witzig TE, Habermann TM, Blum KA, Bartlett NL, Flowers CR, Pitcher BN, Jung SH, Atherton PJ, Tan A, Novotny PJ, Dueck AC
- Lancet Oncol Developing anti-CD19 Antibody-Based Combinations in Lymphoma Lancet Oncol. 2020 Jun 5:S1470-2045(20)30275-8. doi: 10.1016/S1470-2045(20)30275-8. Kuruvilla J
- Lancet Oncol Tafasitamab Plus Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma (L-MIND): A Multicentre, Prospective, Single-Arm, Phase 2 Study Lancet Oncol. 2020 Jun 5:S1470-2045(20)30225-4. doi: 10.1016/S1470-2045(20)30225-4. Salles G, Duell J, González Barca E, Tournilhac O, Jurczak W, Liberati AM, Nagy Z, Obr A, Gaidano G, André M, Kalakonda N, Dreyling M, Weirather J, Dirnberger-Hertweck M, Ambarkhane S, Fingerle-Rowson G, Maddocks K
- Lancet Oncol Sister Mary Joseph Nodule in Mantle Cell Lymphoma 21(6):e337 O'Connor-Byrne N, Glavey S, de Freitas D, Quinn J
- Leukemia Identification of the SRC-family Tyrosine Kinase HCK as a Therapeutic Target in Mantle Cell Lymphoma Leukemia. 2020 Jun 26. doi: 10.1038/s41375-020-0934-6. Lantermans HC, Minderman M, Kuil A, Kersten MJ, Pals ST, Spaargaren M
- Leukemia Frequent Mutations in the Amino-Terminal Domain of BCL7A Impair Its Tumor Suppressor Role in DLBCL Leukemia. 2020 Jun 24. doi: 10.1038/s41375-020-0919-5. Baliñas-Gavira C, Rodríguez MI, Andrades A, Cuadros M, Álvarez-Pérez JC, Álvarez-Prado ÁF, de Yébenes VG, Sánchez-Hernández S, Fernández-Vigo E, Muñoz J, Martín F, Ramiro AR, Martínez-Climent JA, Medina PP
- Leukemia CARM1 Inhibition Reduces Histone Acetyltransferase Activity Causing Synthetic Lethality in CREBBP/EP300-mutated Lymphomas Leukemia. 2020 Jun 24. doi: 10.1038/s41375-020-0908-8. Veazey KJ, Cheng D, Lin K, Villarreal OD, Gao G, Perez-Oquendo M, Van HT, Stratton SA, Green M, Xu H, Lu Y, Bedford MT, Santos MA
- Leukemia Targeted Deep Sequencing Reveals Clonal and Subclonal Mutational Signatures in Adult T-cell leukemia/lymphoma and Defines an Unfavorable Indolent Subtype Leukemia. 2020 Jun 17. doi: 10.1038/s41375-020-0900-3. Marçais A, Lhermitte L, Artesi M, Laurent C, Durkin K, Hahaut V, Rosewick N, Suarez F, Sibon D, Cheminant M, Avettand-Fenoel V, Bruneau J, Georges M, Pique C, Van den Broeke A, Asnafi V, Hermine O
- N Engl J Med Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children 382(23):2207-2219 Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma the Children’s Oncology Group
Myeloma
- Blood Sialic Acid Bearing Paraproteins Are Implicated In Heparin-Like Coagulopathy In Myeloma Patients Blood. 2020 Jun 26:blood.2020005604. doi: 10.1182/blood.2020005604. Saadalla A, Seheult J, Ladwig PM, Tange J, Leger R, Kohlhagen M, Ashrani AA, Murray DL
- Blood MIF as a Biomarker and Therapeutic Target for Overcoming Resistance to Proteasome Inhibitors in Human Myeloma Blood. 2020 Jun 24:blood.2020005795. doi: 10.1182/blood.2020005795. Wang Q, Zhao D, Xian M, Wang Z, Bi E, Su P, Qian J, Ma X, Yang M, Liu L, Zu Y, Pingali SR, Chen K, Cai Z, Yi Q
- Blood Monoclonal Immunoglobulins Promote Bone Loss in Multiple Myeloma Blood. 2020 Jun 23:blood.2020006045. doi: 10.1182/blood.2020006045. Westhrin M, Kovcic V, Zhang Z, Moen SH, Nedal TMV, Bondt A, Holst S, Misund K, Buene G, Sundan A, Waage A, Slørdahl T, Wuhrer M, Standal T
- Blood Clonal Hematopoiesis in Myeloma: Root of All Maladies! 135(26):2330-2331 Neri P
- Blood Biological and Clinical Significance of Dysplastic Hematopoiesis in Patients With Newly Diagnosed Multiple Myeloma 135(26):2375-2387 Maia C, Puig N, Cedena MT, Goicoechea I, Valdes-Mas R, Vazquez I, Chillon MC, Aguirre P, Sarvide S, Gracia-Aznárez FJ, Alkorta G, Calasanz MJ, Garcia-Sanz R, Gonzalez M, Gutierrez NC, Martinez-Lopez J, Perez JJ, Merino J, Moreno C, Burgos L, Alignani D, Botta C, Prosper F, Matarraz S, Orfao A, Oriol A, Teruel AI, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel JF, Paiva B
- Br J Haematol Randomised Phase II Study to Optimise Melphalan, Prednisolone, and Bortezomib in Untreated Multiple Myeloma (JCOG1105) Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16878. Maruyama D, Iida S, Ogawa G, Fukuhara N, Seo S, Miyazaki K, Yoshimitsu M, Kuroda J, Tsukamoto N, Tsujimura H, Hangaishi A, Yamauchi T, Utsumi T, Mizuno I, Takamatsu Y, Nagata Y, Minauchi K, Ohtsuka E, Hanamura I, Yoshida S, Yamasaki S, Suehiro Y, Kamiyama Y, Tsukasaki K, Nagai H
- Br J Haematol Serum Brain-Derived Neurotrophic Factor (BDNF) Concentration Predicts Polyneuropathy and Overall Survival in Multiple Myeloma Patients Br J Haematol. 2020 Jun 22. doi: 10.1111/bjh.16862. Szudy-Szczyrek A, Mlak R, Bury-Kamińska M, Mielnik M, Podgajna M, Kuśmierczuk K, Mazurek M, Homa-Mlak I, Szczyrek M, Krawczyk J, Małecka-Massalska T, Hus M
- Br J Haematol Lenalidomide and Pomalidomide Potently Interfere With Induction of Myeloid-Derived Suppressor Cells in Multiple Myeloma Br J Haematol. 2020 Jun 19. doi: 10.1111/bjh.16881. Kuwahara-Ota S, Shimura Y, Steinebach C, Isa R, Yamaguchi J, Nishiyama D, Fujibayashi Y, Takimoto-Shimomura T, Mizuno Y, Matsumura-Kimoto Y, Tsukamoto T, Chinen Y, Kobayashi T, Horiike S, Taniwaki M, Gütschow M, Kuroda J
- Br J Haematol Venetoclax: The First Anti-Myeloma Agent With a Reliable Biomarker 189(6):1003-1005 Jelinek T
- Br J Haematol Characterisation and Prognostic Impact of Immunoparesis in Relapsed Multiple Myeloma 189(6):1074-1082 Chakraborty R, Rybicki L, Nakashima MO, Dean RM, Faiman BM, Samaras CJ, Rosko N, Dysert H, Valent J, Anwer F
- Br J Haematol Real-world Data on Safety and Efficacy of Venetoclax-Based Regimens in relapsed/refractory t(11;14) Multiple Myeloma 189(6):1136-1140 Basali D, Chakraborty R, Rybicki L, Rosko N, Reed J, Karam M, Schlueter K, Dysert H, Kalaycio M, Valent J
- Br J Haematol Lycorine Targets Multiple Myeloma Stem Cell-Like Cells by Inhibition of Wnt/β-catenin Pathway 189(6):1151-1164 Wang H, Gong Y, Liang L, Xiao L, Yi H, Ye M, Roy M, Xia J, Zhou W, Yang C, Shen X, Zhang B, Li Z, Liu J, Zhou H, Xiao X
- Br J Haematol Association of Hypertension and Cardiac Events in Patients With Multiple Myeloma Receiving Carfilzomib: Practical Management Recommendations Br J Haematol. 2020 Jun 14. doi: 10.1111/bjh.16889. Chavda SJ, Pocock R, Cheesman S, Lee KM, Dowling E, Marks DJB, Kyriakou C, Lee L, Sive J, Wechalekar A, Rabin N, Yong K, Popat R
- Br J Haematol Early Relapse After High-Dose Melphalan Autologous Stem Cell Transplant Predicts Inferior Survival and Is Associated With High Disease Burden and Genetically High-Risk Disease in Multiple Myeloma Br J Haematol. 2020 Jun 10. doi: 10.1111/bjh.16793. Bygrave C, Pawlyn C, Davies F, Craig Z, Cairns D, Hockaday A, Jenner M, Cook G, Drayson M, Owen R, Gregory W, Morgan G, Jackson G, Kaiser M
- Br J Haematol Validation of the UK Myeloma Research Alliance Risk Profile, a New Clinical Prediction Model for Outcome in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Autologous Stem Cell Transplantation; A Population-Based Study From the Danish National Multiple Myeloma Registry Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16806. Redder L, Klausen TW, Vangsted AJ, Gregersen H, Andersen NF, Pedersen RS, Szabo AG, Frederiksen M, Frølund UC, Helleberg C, Nielsen LK, Pedersen PT, Salomo M, Gimsing P, Frederiksen H, Abildgaard N
- Br J Haematol Clinician Attitudes and Practices Toward Measurable Residual Disease in Multiple Myeloma Br J Haematol. 2020 Jun 7. doi: 10.1111/bjh.16805. Derman BA, Jasielec JK, Jakubowiak AJ
- Br J Haematol The Role of High-Dose Melphalan With Autologous Stem-Cell Transplant in Multiple Myeloma: Is It Time for a Paradigm Shift? Br J Haematol. 2020 Jun 5. doi: 10.1111/bjh.16764. Kazandjian D, Mo CC, Landgren O, Richardson PG
- Br J Haematol Platelet Hyperactivation in Multiple Myeloma Is Also Evident in Patients With Premalignant Monoclonal Gammopathy of Undetermined Significance Br J Haematol. 2020 Jun 1. doi: 10.1111/bjh.16774. O'Sullivan LR, Meade-Murphy G, Gilligan OM, Mykytiv V, Young PW, Cahill MR
- Br J Haematol Comparison of MALDI-TOF Mass Spectrometry Analysis of Peripheral Blood and Bone Marrow-Based Flow Cytometry for Tracking Measurable Residual Disease in Patients With Multiple Myeloma 189(5):904-907 Eveillard M, Rustad E, Roshal M, Zhang Y, Ciardiello A, Korde N, Hultcrantz M, Lu S, Shah U, Hassoun H, Smith E, Lesokhin A, Mailankody S, Landgren O, Thoren K
- Haematologica Isatuximab Plus Pomalidomide and Dexamethasone in Elderly Patients With relapsed/refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis Haematologica. 2020 Jun 25:haematol.2020.253450. doi: 10.3324/haematol.2020.253450. Schjesvold FH, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, van de Velde H, Bensfia S, Bringhen S
- Haematologica Reveromycin A, a Novel Acid-Seeking Agent, Ameliorates Bone Destruction and Tumor Growth in Multiple Myeloma Haematologica. 2020 Jun 25:haematol.2019.244418. doi: 10.3324/haematol.2019.244418. Watanabe K, Bat-Erdene A, Tenshin H, Cui Q, Teramachi J, Hiasa M, Oda A, Harada T, Miki H, Sogabe K, Oura M, Sumitani R, Mitsui Y, Endo I, Tanaka E, Kawatani M, Osada H, Matsumoto T, Abe M
- Haematologica Lenalidomide Before and After ASCT for Transplant-Eligible Patients of All Ages in the Randomized, Phase III, Myeloma XI Trial Haematologica. 2020 Jun 4:haematol.2020.247130. doi: 10.3324/haematol.2020.247130. Jackson GH, Davies FE, Pawlyn C, Cairns DA, Striha A, Collett C, Waterhouse A, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Allotey D, Shafeek S, Jenner MW, Cook G, Russell NH, Kaiser MF, Drayson MT, Owen RG, Gregory WM, Morgan GJ; UK NCRI Haematological Oncology Clinical Studies Group
- Haematologica Fc-engineering Significantly Improves the Recruitment of Immune Effector Cells by anti-ICAM-1 Antibody MSH-TP15 for Myeloma Therapy Haematologica. 2020 Jun 4:haematol.2020.251371. doi: 10.3324/haematol.2020.251371. Klausz K, Cieker M, Kellner C, Rösner T, Otte A, Krohn S, Lux A, Nimmerjahn F, Valerius T, Gramatzki M, Peipp M
- Haematologica PIKing the Next Therapeutic Target in Multiple Myeloma 105(6):1474-1475 Caro JL, Davies FE
- Haematologica Hypoxia-induced Long Non-Coding RNA DARS-AS1 Regulates RBM39 Stability to Promote Myeloma Malignancy 105(6):1630-1640 Tong J, Xu X, Zhang Z, Ma C, Xiang R, Liu J, Xu W, Wu C, Li J, Zhan F, Wu Y, Yan H
- Haematologica Identification of PIKfyve Kinase as a Target in Multiple Myeloma 105(6):1641-1649 de Campos CB, Zhu YX, Sepetov N, Romanov S, Bruins LA, Shi CX, Stein CK, Petit JL, Polito AN, Sharik ME, Meermeier EW, Ahmann GJ, Armenta IDL, Kruse J, Bergsagel PL, Chesi M, Meurice N, Braggio E, Stewart AK
- Haematologica Health-related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated With Either Thalidomide or Lenalidomide-Based Regimen Until Progression: A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study 105(6):1650-1659 Nielsen LK, Stege C, Lissenberg-Witte B, van der Holt B, Mellqvist UH, Salomo M, Bos G, Levin MD, Visser-Wisselaar H, Hansson M, van der Velden A, Deenik W, Coenen J, Hinge M, Klein S, Tanis B, Szatkowski D, Brouwer R, Westerman M, Leys R, Sinnige H, Haukås E, van der Hem K, Durian M, Gimsing P, van de Donk N, Sonneveld P, Waage A, Abildgaard N, Zweegman S
- Haematologica Effect of Daratumumab on Normal Plasma Cells, Polyclonal Immunoglobulin Levels, and Vaccination Responses in Extensively Pre-Treated Multiple Myeloma Patients 105(6):e302-e306 Frerichs KA, Bosman PWC, van Velzen JF, Fraaij PLA, Koopmans MPG, Rimmelzwaan GF, Nijhof IS, Bloem AC, Mutis T, Zweegman S, van de Donk NWCJ
- J Clin Oncol Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy J Clin Oncol. 2020 Jun 23:JCO2000298. doi: 10.1200/JCO.20.00298. Bridoux F, Arnulf B, Karlin L, Blin N, Rabot N, Macro M, Audard V, Belhadj K, Pegourie B, Gobert P, Cornec Le Gall E, Joly B, Karras A, Jaccard A, Augeul-Meunier K, Manier S, Royer B, Caillot D, Tiab M, Delbes S, Suarez F, Vigneau C, Caillard S, Arakelyan-Laboure N, Roos-Weil D, Chevret S, Fermand JP; MYRE study group
- J Clin Oncol Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma 38(17):1928-1937 Joseph NS, Kaufman JL, Dhodapkar MV, Hofmeister CC, Almaula DK, Heffner LT, Gupta VA, Boise LH, Lonial S, Nooka AK
- Lancet Haematol Daratumumab: A Game Changer in Myeloma Therapy 7(6):e426-e427 Ludwig H
- Lancet Haematol Intensification and Consolidation Therapy in Multiple Myeloma in the Current Era 7(6):e427-e429 Nadeem O, Ghobrial IM
- Lancet Haematol Management of Patients With Multiple Myeloma During the COVID-19 Pandemic 7(6):e435-e437 Malard F, Mohty M
- Lancet Haematol Should the Emphasis Be on Induction or Consolidation Therapy in Transplant-Eligible, Newly Diagnosed Multiple Myeloma? 7(6):e445-e446 Krishnan A, Sonneveld P
- Lancet Haematol Daratumumab Monotherapy in Patients With Heavily Pretreated Relapsed or Refractory Multiple Myeloma: Final Results From the Phase 2 GEN501 and SIRIUS Trials 7(6):e447-e455 Usmani SZ, Nahi H, Plesner T, Weiss BM, Bahlis NJ, Belch A, Voorhees PM, Laubach JP, van de Donk NWCJ, Ahmadi T, Uhlar CM, Wang J, Feng H, Qi M, Richardson PG, Lonial S
- Lancet Haematol Autologous Haematopoietic Stem-Cell Transplantation Versus Bortezomib-Melphalan-Prednisone, With or Without Bortezomib-Lenalidomide-Dexamethasone Consolidation Therapy, and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma (EMN02/HO95): A Multicentre, Randomised, Open-Label, Phase 3 Study 7(6):e456-e468 Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P
- Leukemia Development of CAR-T Cell Therapies for Multiple Myeloma Leukemia. 2020 Jun 22. doi: 10.1038/s41375-020-0930-x. Gagelmann N, Riecken K, Wolschke C, Berger C, Ayuk FA, Fehse B, Kröger N
- Leukemia Defining the Vulnerable Patient With Myeloma-A Frailty Position Paper of the European Myeloma Network Leukemia. 2020 Jun 18. doi: 10.1038/s41375-020-0918-6. Cook G, Larocca A, Facon T, Zweegman S, Engelhardt M
- Leukemia Prediction of Immunomodulatory Drugs (IMiDs) Sensitivity in Myeloma via Determination of Baseline Anti-Oxidative Stress Capacity Leukemia. 2020 Jun 5. doi: 10.1038/s41375-020-0881-2. Mountjoy L, Sebastian S, Jain T, Hilal T, Gonzalez-Velez M, Girardo M, Ahmann G, Larsen J, Bergsagel L, Fonseca R
- Leukemia Circulating Tumor Cells for Comprehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma Leukemia. 2020 Jun 1. doi: 10.1038/s41375-020-0883-0. Garcés JJ, Bretones G, Burgos L, Valdes-Mas R, Puig N, Cedena MT, Alignani D, Rodriguez I, Puente DÁ, Álvarez MG, Goicoechea I, Rodriguez S, Calasanz MJ, Agirre X, Flores-Montero J, Sanoja-Flores L, Rodriguez-Otero P, Rios R, Martinez-Lopez J, Millacoy P, Palomera L, Del Orbe R, Pérez-Montaña A, El Omri H, Prosper F, Mateos MV, Rosiñol L, Blade J, Lahuerta JJ, Orfao A, Lopez-Otin C, San Miguel JF, Paiva B; GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group
- Leukemia Multiple Myeloma and COVID-19 Leukemia. 2020 Jun 1. doi: 10.1038/s41375-020-0879-9. Dhakal B, D'Souza A, Chhabra S, Hari P
SCT
- Blood Risk Score to Predict Event-Free Survival After Hematopoietic Cell Transplant for Sickle Cell Disease Blood. 2020 Jun 9:blood.2020005687. doi: 10.1182/blood.2020005687. Brazauskas R, Scigliuolo GM, Wang HL, Cappelli B, Ruggeri AL, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Panepinto JA, Rondelli D, Shenoy S, Walters MC, Wagner JE, Tisdale JF, Gluckman E, Eapen M
- Blood Impact of TKI Maintenance Post-Allogeneic Transplant in Philadelphia Positive Acute Lymphoblastic Leukemia Blood. 2020 Jun 3:blood.2019004685. doi: 10.1182/blood.2019004685. Saini NY, Marin D, Ledesma C, Delgado R, Rondon G, Popat U, Bashir Q, Hosing C, Nieto Y, Alousi A, Qazilbash MH, Ciurea SO, Shpall EJ, Khouri IF, Kantarjian HM, Jabbour E, Ravandi F, Champlin R, Kebriaei P
- Blood House Calls for Stem Cell Transplants During the COVID-19 Pandemic Blood. 2020 Jun 2:blood.2020006573. doi: 10.1182/blood.2020006573. Sung AD, R Nichols K, Chao NJ
- Blood A Multicenter Phase 1 Study of Nivolumab for Relapsed Hematologic Malignancies After Allogeneic Transplantation 135(24):2182-2191 Davids MS, Kim HT, Costello C, Herrera AF, Locke FL, Maegawa RO, Savell A, Mazzeo M, Anderson A, Boardman AP, Weber A, Avigan D, Chen YB, Nikiforow S, Ho VT, Cutler C, Alyea EP, Bachireddy P, Wu CJ, Ritz J, Streicher H, Ball ED, Bashey A, Soiffer RJ, Armand P
- Blood Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report 135(23):2094-2105 Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S, Prockop SE, Quinones R, Goldman FD, Quigg TC, Chandrakasan S, Smith AR, Parikh S, Dávila Saldaña BJ, Thakar MS, Phelan R, Shenoy S, Forbes LR, Martinez C, Chellapandian D, Shereck E, Miller HK, Kapoor N, Barnum JL, Chong H, Shyr DC, Chen K, Abu-Arja R, Shah AJ, Weinacht KG, Moore TB, Joshi A, DeSantes KB, Gillio AP, Cuvelier GDE, Keller MD, Rozmus J, Torgerson T, Pulsipher MA, Haddad E, Sullivan KE, Logan BR, Kohn DB, Puck JM, Notarangelo LD, Pai SY, Rawlings DJ, Cowan MJ
- Br J Haematol A Key Step Towards Setting a Benchmark for Tackling Transplant-Associated Thrombotic Microangiopathy 189(6):1006-1009 Scordo M, Giralt SA
- Br J Haematol Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy 189(6):1171-1181 Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M
- Br J Haematol Early Relapse After High-Dose Melphalan Autologous Stem Cell Transplant Predicts Inferior Survival and Is Associated With High Disease Burden and Genetically High-Risk Disease in Multiple Myeloma Br J Haematol. 2020 Jun 10. doi: 10.1111/bjh.16793. Bygrave C, Pawlyn C, Davies F, Craig Z, Cairns D, Hockaday A, Jenner M, Cook G, Drayson M, Owen R, Gregory W, Morgan G, Jackson G, Kaiser M
- Br J Haematol Validation of the UK Myeloma Research Alliance Risk Profile, a New Clinical Prediction Model for Outcome in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Autologous Stem Cell Transplantation; A Population-Based Study From the Danish National Multiple Myeloma Registry Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16806. Redder L, Klausen TW, Vangsted AJ, Gregersen H, Andersen NF, Pedersen RS, Szabo AG, Frederiksen M, Frølund UC, Helleberg C, Nielsen LK, Pedersen PT, Salomo M, Gimsing P, Frederiksen H, Abildgaard N
- Br J Haematol The Role of High-Dose Melphalan With Autologous Stem-Cell Transplant in Multiple Myeloma: Is It Time for a Paradigm Shift? Br J Haematol. 2020 Jun 5. doi: 10.1111/bjh.16764. Kazandjian D, Mo CC, Landgren O, Richardson PG
- Br J Haematol Outcomes of Allogeneic Stem Cell Transplantation for Patients With t(6:9) AML- A Strong Case for Allogeneic Stem Cell Transplantation in First Complete Remission 189(5):806-808 Stahl M, Tallman MS
- Br J Haematol Allogeneic Stem Cell Transplantation in AML With t(6;9)(p23;q34);DEK-NUP214 Shows a Favourable Outcome When Performed in First Complete Remission 189(5):920-925 Díaz-Beyá M, Labopin M, Maertens J, Alijurf M, Passweg J, Dietrich B, Schouten H, Socié G, Schaap N, Schwerdtfeger R, Volin L, Michallet M, Polge E, Sierra J, Mohty M, Esteve J, Nagler A; Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
- Haematologica Efficacy of Minimal Residual Disease Driven Immune-Intervention After Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Chronic Lymphocytic Leukemia: Results of a Prospective Multicentric Trial Haematologica. 2020 Jun 11:haematol.2019.239566. doi: 10.3324/haematol.2019.239566. Tournilhac O, Le Garff-Tavernier M, Nguyen Quoc S, Forcade E, Chevallier P, Legrand-Izadifar F, Damaj GL, Michonneau D, Tomowiak C, Borel C, Orvain C, Turlure P, Redjou R, Guillerm G, Vincent L, Simand C, Lemal R, Quiney C, Combes P, Pereira B, Calvet L, Cabrespine A, Bay JO, Leblond V, Dhédin N; French Innovative Leukemia Organization (FILO); Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- Haematologica Lenalidomide Before and After ASCT for Transplant-Eligible Patients of All Ages in the Randomized, Phase III, Myeloma XI Trial Haematologica. 2020 Jun 4:haematol.2020.247130. doi: 10.3324/haematol.2020.247130. Jackson GH, Davies FE, Pawlyn C, Cairns DA, Striha A, Collett C, Waterhouse A, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Allotey D, Shafeek S, Jenner MW, Cook G, Russell NH, Kaiser MF, Drayson MT, Owen RG, Gregory WM, Morgan GJ; UK NCRI Haematological Oncology Clinical Studies Group
- Haematologica Allogeneic Hematopoietic Cell Transplantation With Non-Myeloablative Conditioning for Patients With Hematologic Malignancies: Improved Outcomes Over Two Decades Haematologica. 2020 Jun 4:haematol.2020.248187. doi: 10.3324/haematol.2020.248187. Cooper JP, Storer BE, Granot N, Gyurkocza B, Sorror ML, Chauncey TR, Shizuru J, Franke GN, Maris MB, Boyer M, Bruno B, Sahebi F, Langston AA, Hari P, Agura ED, Petersen SL, Maziarz RT, Bethge W, Asch J, Gutman JA, Olesen G, Yeager AM, Hübel K, Hogan WJ, Maloney DG, Mielcarek M, Martin PJ, Flowers MED, Georges GE, Woolfrey AE, Deeg HJ, Scott BL, McDonald GB, Storb R, Sandmaier BM
- Haematologica Clinical Practice Recommendation on Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients With FLT3-internal Tandem Duplication: A Position Statement From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 105(6):1507-1516 Bazarbachi A, Bug G, Baron F, Brissot E, Ciceri F, Dalle IA, Döhner H, Esteve J, Floisand Y, Giebel S, Gilleece M, Gorin NC, Jabbour E, Aljurf M, Kantarjian H, Kharfan-Dabaja M, Labopin M, Lanza F, Malard F, Peric Z, Prebet T, Ravandi F, Ruggeri A, Sanz J, Schmid C, Shouval R, Spyridonidis A, Versluis J, Vey N, Savani BN, Nagler A, Mohty M
- Haematologica Allogeneic Stem Cell Transplantation in Second Complete Remission for Core Binding Factor Acute Myeloid Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 105(6):1723-1730 Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A
- Haematologica Yttrium-90-labeled anti-CD45 Antibody Followed by a Reduced-Intensity Hematopoietic Cell Transplantation for Patients With Relapsed/Refractory Leukemia or Myelodysplasia 105(6):1731-1737 Vo P, Gooley TA, Rajendran JG, Fisher DR, Orozco JJ, Green DJ, Gopal AK, Haaf R, Nartea M, Storb R, Appelbaum FR, Press OW, Pagel JM, Sandmaier BM
- Haematologica Mental Fatigue After Allogeneic Hematopoietic Stem Cell Transplantation Is Associated With Cognitive Dysfunction, but Not Central Nervous System Inflammation 105(6):e310-e314 Boberg E, Kadri N, Winterling J, Davies LC, Björklund A, Msghina M, Iacobaeus E, Le Blanc K
- J Clin Oncol Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT 38(18):2062-2076 Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ
- Lancet Haematol Autologous Haematopoietic Stem-Cell Transplantation Versus Bortezomib-Melphalan-Prednisone, With or Without Bortezomib-Lenalidomide-Dexamethasone Consolidation Therapy, and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma (EMN02/HO95): A Multicentre, Randomised, Open-Label, Phase 3 Study 7(6):e456-e468 Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P
- Leukemia Comparison of Efficacy and Health-Related Quality of Life of First-Line Haploidentical Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Infusion and First-Line Immunosuppressive Therapy for Acquired Severe Aplastic Anemia Leukemia. 2020 Jun 26. doi: 10.1038/s41375-020-0933-7. Liu L, Zhang Y, Jiao W, Zhou H, Wang Q, Jin S, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Lei M, Yan X, Miao M, Wu D
- Leukemia Impact of Pretransplant Measurable Residual Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML 34(6):1577-1587 Morsink LM, Othus M, Bezerra ED, Wood BL, Fang M, Sandmaier BM, Mielcarek M, Schoch G, Storb R, Deeg HJ, Appelbaum FR, Walter RB
HSC
- Blood The BET Inhibitor CPI203 Promotes Ex Vivo Expansion of Cord Blood Long-Term Repopulating HSCs and Megakaryocytes Blood. 2020 Jun 29:blood.2020005357. doi: 10.1182/blood.2020005357. Hua P, Hester J, Adigbli G, Li R, Psaila B, Roy A, Bataille CJR, Wynne GM, Jackson T, Milne TA, Russell A, Davies J, Roberts I, Issa F, Watt SM
- Blood Activation of the Receptor Tyrosine Kinase, RET, Improves Long-Term Hematopoietic Stem Cell Outgrowth and Potency Blood. 2020 Jun 26:blood.2020006302. doi: 10.1182/blood.2020006302. Grey W, Chauhan R, Piganeau M, Huerga Encabo H, Garcia-Albornoz M, McDonald NQ, Bonnet D
- Blood Lysine-specific Demethylase 1A (LSD1) Restricts Ex Vivo Propagation of Human HSCs and Is a Target of UM171 Blood. 2020 Jun 24:blood.2020005827. doi: 10.1182/blood.2020005827. Subramaniam A, Žemaitis K, Safaee Talkhoncheh M, Yudovich D, Bäckström A, Debnath S, Chen J, Jain MV, Galeev R, Gaetani M, Zubarev RA, Larsson J
- Blood Hematopoietic Stem Cells Acquire Survival Advantage by Loss of RUNX1 Methylation Identified in Familial Leukemia Blood. 2020 Jun 23:blood.2019004292. doi: 10.1182/blood.2019004292. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CQ, Tokunaga K, Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T
- Blood Yap1-Scribble Polarization Is Required for Hematopoietic Stem Cell Division and Fate Blood. 2020 Jun 1:blood.2019004113. doi: 10.1182/blood.2019004113. Althoff M, Nayak R, Hegde S, Wellendorf A, Bohan B, Filippi MD, Xin M, Lu R, Geiger H, Zheng Y, Diaz-Meco MT, Moscat J, Cancelas JA
- Haematologica Efficacy of Minimal Residual Disease Driven Immune-Intervention After Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Chronic Lymphocytic Leukemia: Results of a Prospective Multicentric Trial Haematologica. 2020 Jun 11:haematol.2019.239566. doi: 10.3324/haematol.2019.239566. Tournilhac O, Le Garff-Tavernier M, Nguyen Quoc S, Forcade E, Chevallier P, Legrand-Izadifar F, Damaj GL, Michonneau D, Tomowiak C, Borel C, Orvain C, Turlure P, Redjou R, Guillerm G, Vincent L, Simand C, Lemal R, Quiney C, Combes P, Pereira B, Calvet L, Cabrespine A, Bay JO, Leblond V, Dhédin N; French Innovative Leukemia Organization (FILO); Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- Haematologica Clinical Practice Recommendation on Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients With FLT3-internal Tandem Duplication: A Position Statement From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 105(6):1507-1516 Bazarbachi A, Bug G, Baron F, Brissot E, Ciceri F, Dalle IA, Döhner H, Esteve J, Floisand Y, Giebel S, Gilleece M, Gorin NC, Jabbour E, Aljurf M, Kantarjian H, Kharfan-Dabaja M, Labopin M, Lanza F, Malard F, Peric Z, Prebet T, Ravandi F, Ruggeri A, Sanz J, Schmid C, Shouval R, Spyridonidis A, Versluis J, Vey N, Savani BN, Nagler A, Mohty M
- Haematologica Mental Fatigue After Allogeneic Hematopoietic Stem Cell Transplantation Is Associated With Cognitive Dysfunction, but Not Central Nervous System Inflammation 105(6):e310-e314 Boberg E, Kadri N, Winterling J, Davies LC, Björklund A, Msghina M, Iacobaeus E, Le Blanc K
- Lancet Haematol Autologous Haematopoietic Stem-Cell Transplantation Versus Bortezomib-Melphalan-Prednisone, With or Without Bortezomib-Lenalidomide-Dexamethasone Consolidation Therapy, and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma (EMN02/HO95): A Multicentre, Randomised, Open-Label, Phase 3 Study 7(6):e456-e468 Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P
- Leukemia Comparison of Efficacy and Health-Related Quality of Life of First-Line Haploidentical Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Infusion and First-Line Immunosuppressive Therapy for Acquired Severe Aplastic Anemia Leukemia. 2020 Jun 26. doi: 10.1038/s41375-020-0933-7. Liu L, Zhang Y, Jiao W, Zhou H, Wang Q, Jin S, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Lei M, Yan X, Miao M, Wu D
- Leukemia S100A6 Is a Critical Regulator of Hematopoietic Stem Cells Leukemia. 2020 Jun 19. doi: 10.1038/s41375-020-0901-2. Grahn THM, Niroula A, Végvári Á, Oburoglu L, Pertesi M, Warsi S, Safi F, Miharada N, Garcia SC, Siva K, Liu Y, Rörby E, Nilsson B, Zubarev RA, Karlsson S
- Leukemia SARS-CoV-2 Infection and Overactivation of Nlrp3 Inflammasome as a Trigger of Cytokine “Storm” and Risk Factor for Damage of Hematopoietic Stem Cells Leukemia. 2020 Jun 1:1–4. doi: 10.1038/s41375-020-0887-9. Ratajczak MZ, Kucia M
- Leukemia Despite Mutation Acquisition in Hematopoietic Stem Cells, JMML-propagating Cells Are Not Always Restricted to This Compartment 34(6):1658-1668 Caye A, Rouault-Pierre K, Strullu M, Lainey E, Abarrategi A, Fenneteau O, Arfeuille C, Osman J, Cassinat B, Pereira S, Anjos-Afonso F, Currie E, Ariza-McNaughton L, Barlogis V, Dalle JH, Baruchel A, Chomienne C, Cavé H, Bonnet D
Anemia
- Blood How I Treat Anemia in the Perisurgical Setting Blood. 2020 Jun 18:blood.2019003945. doi: 10.1182/blood.2019003945. Shander A, Kaufman M, Goodnough LT
- Blood How We Treat Renal Anemia Blood. 2020 Jun 18:blood.2019004330. doi: 10.1182/blood.2019004330. Fishbane S, Coyne DW
- Blood How I Treat Cancer Anemia Blood. 2020 Jun 18:blood.2019004017. doi: 10.1182/blood.2019004017. Gilreath JA, Rodgers GM
- Blood Introduction to a How I Treat Series on Anemia Blood. 2020 Jun 18:blood.2020007025. doi: 10.1182/blood.2020007025. Cazzola M
- Blood A Homozygous Deletion in the SLC19A1 Gene as a Cause of Folate-Dependent Recurrent Megaloblastic Anemia 135(26):2427-2431 Svaton M, Skvarova Kramarzova K, Kanderova V, Mancikova A, Smisek P, Jesina P, Krijt J, Stiburkova B, Dobrovolny R, Sokolova J, Bakardjieva-Mihaylova V, Vodickova E, Rackova M, Stuchly J, Kalina T, Stary J, Trka J, Fronkova E, Kozich V
- Br J Haematol Longitudinal Evaluation of Eltrombopag in Paediatric Acquired Severe Aplastic Anaemia Br J Haematol. 2020 Jun 12. doi: 10.1111/bjh.16766. Filippidou M, Avgerinou G, Tsipou H, Tourkantoni N, Katsibardi K, Vlachou A, Roka K, Solomou E, Kattamis A
- Br J Haematol Distinctive and Common Features of Moderate Aplastic Anaemia 189(5):967-975 Patel BJ, Barot SV, Kuzmanovic T, Kerr C, Przychodzen BP, Thota S, Lee S, Patel S, Radivoyevitch T, Lichtin A, Advani A, Kalaycio M, Sekeres MA, Carraway HE, Maciejewski JP
- Haematologica Anemia and Hemodilution: Analysis of a Single Center Cohort Based on 2858 Red Cell Mass Measurements Haematologica. 2020 Jun 25:haematol.2020.249409. doi: 10.3324/haematol.2020.249409. Drevon L, Maslah N, Soret-Dulphy J, Dosquet C, Ravdan O, Vercellino L, Belkhodja C, Parquet N, Brignier AC, Schlageter MH, Cassinat B, Kiladjian JJ, Chomienne C, Giraudier S; FIM, French Intergroup for Myeloproliferative disorders
- Haematologica Hydroxyurea to Lower Transcranial Doppler Velocities and Prevent Primary Stroke: The Uganda NOHARM Sickle Cell Anemia Cohort 105(6):e272-e275 Opoka RO, Hume HA, Latham TS, Lane A, Williams O, Tymon J, Nakafeero M, Kasirye P, Ndugwa CM, John CC, Ware RE
- Leukemia Comparison of Efficacy and Health-Related Quality of Life of First-Line Haploidentical Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Infusion and First-Line Immunosuppressive Therapy for Acquired Severe Aplastic Anemia Leukemia. 2020 Jun 26. doi: 10.1038/s41375-020-0933-7. Liu L, Zhang Y, Jiao W, Zhou H, Wang Q, Jin S, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Lei M, Yan X, Miao M, Wu D
- N Engl J Med Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa 382(26):2524-2533 John CC, Opoka RO, Latham TS, Hume HA, Nabaggala C, Kasirye P, Ndugwa CM, Lane A, Ware RE
ITP
- Blood Racial Variation in ITP Prevalence and Chronic Disease Phenotype Suggests Biological Differences Blood. 2020 Jun 19:blood.2020004888. doi: 10.1182/blood.2020004888. Kim TO, Grimes AB, Kirk SE, Gilbert MM, Reed HD, Staggers KA, Walker LA, Arulselvan A, Cohen AS, Lambert MP, Despotovic JM
- Blood Inhibition of Platelet Phagocytosis as an in Vitro Predictor for Therapeutic Potential of RBC Antibodies in Murine ITP 135(26):2420-2424 Khan R, Menard M, Jen CC, Chen X, Norris PAA, Lazarus AH
- Blood The Never-Ending Enigma of Immune Thrombocytopenia 135(25):2207-2209 Hoffmeister KM
- Blood Mechanisms of anti-GPIbα Antibody-Induced Thrombocytopenia in Mice 135(25):2292-2301 Morodomi Y, Kanaji S, Won E, Ruggeri ZM, Kanaji T
- Br J Haematol Practical Guidance for the Management of Adults With Immune Thrombocytopenia During the COVID-19 Pandemic 189(6):1038-1043 Pavord S, Thachil J, Hunt BJ, Murphy M, Lowe G, Laffan M, Makris M, Newland AC, Provan D, Grainger JD, Hill QA
- Br J Haematol Fatigue Is Common in Paediatric Immune Thrombocytopenia and Improves With Second-Line Treatments Br J Haematol. 2020 Jun 13. doi: 10.1111/bjh.16855. White MH, Bennett CM
- Br J Haematol ITP Flare With Mild COVID-19 Infection in Pregnancy: A Case Report Br J Haematol. 2020 Jun 9. doi: 10.1111/bjh.16928. Nesr G, Garnett C, Bailey C, Arami S
- Br J Haematol Fatigue in Children and Adolescents With Immune Thrombocytopenia Br J Haematol. 2020 Jun 5. doi: 10.1111/bjh.16751. Grace RF, Klaassen RJ, Shimano KA, Lambert MP, Grimes A, Bussel JB, Breakey VR, Pastore YD, Black V, Overholt K, Bhat R, Forbes PW, Neunert C
- Br J Haematol Second-line Treatment Trends and Long-Term Outcomes of 392 Children With Chronic Immune Thrombocytopenic Purpura: The French Experience Over the Past 25 Years 189(5):931-942 Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, Bayart S, Bertrand Y, Michel G, Jeziorski E, Thomas C, Abouchallah W, Viard F, Guitton C, Cheikh N, Pellier I, Carausu L, Droz C, Leblanc T, Aladjidi N; Centre de Référence National des Cytopénies Auto-immunes de l’Enfant (CEREVANCE)